Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_000123.4(ERCC5):c.83C>A (p.Ala28Asp)	BIVM-ERCC5|ERCC5	A28D	Xeroderma pigmentosum, group G	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000041495	13	103498699	13	102846349	41495	49931	rs267607281	NC_000013.11:102846348:C:A
NM_000123.4(ERCC5):c.215C>A (p.Pro72His)	BIVM-ERCC5|ERCC5	P72H, P526H	Xeroderma pigmentosum group g/Cockayne syndrome	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000016572	13	103504594	13	102852244	16572	31611	rs121434574	NC_000013.11:102852243:C:A
NM_000123.4(ERCC5):c.787C>T (p.Arg263Ter)	BIVM-ERCC5|ERCC5	R263*, R717*	Xeroderma pigmentosum group g/Cockayne syndrome	Pathogenic(Last reviewed: Mar 19, 2020)	no assertion criteria provided	VCV000016570	13	103513971	13	102861621	16570	31609	rs121434572	NC_000013.11:102861620:C:T
NM_001983.4(ERCC1):c.676A>T (p.Lys226Ter)	ERCC1	K226*	Cockayne syndrome	Pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000264678	19	45918145	19	45414887	264678	259255	rs886039224	NC_000019.10:45414886:T:A
NM_001983.4(ERCC1):c.693C>G (p.Phe231Leu)	ERCC1	F231L	Cerebrooculofacioskeletal syndrome 4|Cockayne syndrome	Pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000016778	19	45918128	19	45414870	16778	31817	rs121913028	NC_000019.10:45414869:G:C
NM_000400.4(ERCC2):c.1847G>C (p.Arg616Pro)	ERCC2	R616P	Cerebrooculofacioskeletal syndrome 2|Xeroderma pigmentosum, group D|Trichothiodystrophy 1, photosensitive|not provided|Xeroderma pigmentosum|Xeroderma pigmentosum, group D	Pathogenic(Last reviewed: May 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000329508	19	45856059	19	45352801	329508	349077	rs376556895	NC_000019.10:45352800:C:G
NM_000122.2(ERCC3):c.1015G>T (p.Val339Phe)	ERCC3	V275F, V339F	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319558	2	128046248	2	127288672	1319558	1309810		NC_000002.12:127288671:C:A
NM_000122.2(ERCC3):c.1130A>T (p.Gln377Leu)	ERCC3	Q313L, Q377L	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319557	2	128044491	2	127286915	1319557	1309809		NC_000002.12:127286914:T:A
NM_000122.2(ERCC3):c.1162C>T (p.Gln388Ter)	ERCC3	Q324*, Q388*	Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319556	2	128044459	2	127286883	1319556	1309808		NC_000002.12:127286882:G:A
NM_000122.2(ERCC3):c.1549G>A (p.Glu517Lys)	ERCC3	E453K, E517K	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319554	2	128036930	2	127279354	1319554	1309806		NC_000002.12:127279353:C:T
NM_000122.2(ERCC3):c.1559G>A (p.Arg520Gln)	ERCC3	R456Q, R520Q	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319553	2	128036920	2	127279344	1319553	1309805		NC_000002.12:127279343:C:T
NM_000122.2(ERCC3):c.1895C>T (p.Ser632Phe)	ERCC3	S568F, S632F	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319552	2	128028962	2	127271386	1319552	1309804		NC_000002.12:127271385:G:A
NM_000122.2(ERCC3):c.1900C>T (p.Arg634Cys)	ERCC3	R570C, R634C	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319551	2	128028957	2	127271381	1319551	1309803		NC_000002.12:127271380:G:A
NM_000122.2(ERCC3):c.2259C>T (p.Ala753=)	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319550	2	128015262	2	127257686	1319550	1309802		NC_000002.12:127257685:G:A
NM_000122.2(ERCC3):c.500A>G (p.Lys167Arg)	ERCC3	K103R, K167R	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319240	2	128047821	2	127290245	1319240	1309493		NC_000002.12:127290244:T:C
NM_000122.2(ERCC3):c.822+5G>A	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319239	2	128046908	2	127289332	1319239	1309492		NC_000002.12:127289331:C:T
NM_000122.2(ERCC3):c.1354C>T (p.Arg452Ter)	ERCC3	R388*, R452*	Xeroderma pigmentosum, complementation group b	Likely pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, single submitter	VCV000995893	2	128038196	2	127280620	995893	983584		NC_000002.12:127280619:G:A
NM_000122.2(ERCC3):c.1182C>T (p.Ser394=)	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000894783	2	128044439	2	127286863	894783	881018		NC_000002.12:127286862:G:A
NM_000122.2(ERCC3):c.1411G>A (p.Val471Ile)	ERCC3	V471I, V407I	Xeroderma pigmentosum, complementation group b|not provided	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000894782	2	128038139	2	127280563	894782	881017		NC_000002.12:127280562:C:T
NM_000122.2(ERCC3):c.-31G>A	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000893903	2	128051688	2	127294112	893903	881026		NC_000002.12:127294111:C:T
NM_000122.2(ERCC3):c.131A>G (p.Lys44Arg)	ERCC3	K44R	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000893902	2	128051192	2	127293616	893902	881025		NC_000002.12:127293615:T:C
NM_000122.2(ERCC3):c.144G>C (p.Glu48Asp)	ERCC3	E48D	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000893901	2	128051179	2	127293603	893901	881024		NC_000002.12:127293602:C:G
NM_000122.2(ERCC3):c.1911C>G (p.Ala637=)	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000893873	2	128028946	2	127271370	893873	881016		NC_000002.12:127271369:G:C
NM_000122.2(ERCC3):c.1986G>A (p.Leu662=)	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000893872	2	128018882	2	127261306	893872	881015		NC_000002.12:127261305:C:T
NM_000122.2(ERCC3):c.2080G>T (p.Ala694Ser)	ERCC3	A630S, A694S	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000893871	2	128017009	2	127259433	893871	881014		NC_000002.12:127259432:C:A
NM_000122.2(ERCC3):c.2087T>G (p.Met696Arg)	ERCC3	M632R, M696R	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000893870	2	128017002	2	127259426	893870	881013		NC_000002.12:127259425:A:C
NM_000122.2(ERCC3):c.314A>G (p.Glu105Gly)	ERCC3	E41G, E105G	Xeroderma pigmentosum, complementation group b|not provided	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000893613	2	128050343	2	127292767	893613	881023		NC_000002.12:127292766:T:C
NM_000122.2(ERCC3):c.529G>A (p.Val177Ile)	ERCC3	V113I, V177I	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000893612	2	128047393	2	127289817	893612	881022		NC_000002.12:127289816:C:T
NM_000122.2(ERCC3):c.2224C>T (p.Arg742Trp)	ERCC3	R678W, R742W	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000893584	2	128015297	2	127257721	893584	881012		NC_000002.12:127257720:G:A
NM_000122.2(ERCC3):c.*83C>T	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000893583	2	128015089	2	127257513	893583	881011		NC_000002.12:127257512:G:A
NM_000122.2(ERCC3):c.1076A>G (p.Lys359Arg)	ERCC3	K359R, K295R	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000892812	2	128044545	2	127286969	892812	881021		NC_000002.12:127286968:T:C
NM_000122.2(ERCC3):c.1110T>C (p.Ser370=)	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000892811	2	128044511	2	127286935	892811	881020		NC_000002.12:127286934:A:G
NM_000122.2(ERCC3):c.1152T>C (p.Ile384=)	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000892810	2	128044469	2	127286893	892810	881019		NC_000002.12:127286892:A:G
NM_000122.2(ERCC3):c.*138G>C	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000892773	2	128015034	2	127257458	892773	881010		NC_000002.12:127257457:C:G
NM_000122.2(ERCC3):c.*220G>C	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000892772	2	128014952	2	127257376	892772	881009		NC_000002.12:127257375:C:G
NM_000122.2(ERCC3):c.1700C>T (p.Ala567Val)	ERCC3	A503V, A567V	Xeroderma pigmentosum, complementation group b|not provided	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000808797	2	128036779	2	127279203	808797	794764	rs1474396878	NC_000002.12:127279202:G:A
NM_000122.2(ERCC3):c.1291A>C (p.Lys431Gln)	ERCC3	K431Q, K367Q	Xeroderma pigmentosum, complementation group b|not provided	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000804794	2	128044330	2	127286754	804794	792906	rs1573957226	NC_000002.12:127286753:T:G
NM_000122.2(ERCC3):c.460C>T (p.Gln154Ter)	ERCC3	Q154*, Q90*	Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801749	2	128050197	2	127292621	801749	790042	rs1404293670	NC_000002.12:127292620:G:A
NM_000122.2(ERCC3):c.1828-36C>T	ERCC3		Xeroderma pigmentosum, complementation group b	Benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801748	2	128029065	2	127271489	801748	790041	rs113416031	NC_000002.12:127271488:G:A
NM_000122.2(ERCC3):c.1828-35C>T	ERCC3		Xeroderma pigmentosum, complementation group b	Benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801747	2	128029064	2	127271488	801747	790040	rs1444307407	NC_000002.12:127271487:G:A
NM_000122.2(ERCC3):c.1828-33C>T	ERCC3		Xeroderma pigmentosum, complementation group b	Benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801746	2	128029062	2	127271486	801746	790039	rs745775695	NC_000002.12:127271485:G:A
NM_000122.2(ERCC3):c.1828-32A>T	ERCC3		Xeroderma pigmentosum, complementation group b	Benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801745	2	128029061	2	127271485	801745	790038	rs773954881	NC_000002.12:127271484:T:A
NM_000122.2(ERCC3):c.1933C>T (p.Arg645Ter)	ERCC3	R581*, R645*	Xeroderma pigmentosum, complementation group b	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801744	2	128028924	2	127271348	801744	790037	rs1404157087	NC_000002.12:127271347:G:A
NM_000122.2(ERCC3):c.1335C>T (p.Thr445=)	ERCC3		Xeroderma pigmentosum, complementation group b|not provided	Benign(Last reviewed: Nov 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000783340	2	128044286	2	127286710	783340	707709	rs4150422	NC_000002.12:127286709:G:A
NM_000122.2(ERCC3):c.2218-6C>T	ERCC3		Xeroderma pigmentosum, complementation group b|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 18, 2018)	criteria provided, conflicting interpretations	VCV000758079	2	128015309	2	127257733	758079	774569	rs200733704	NC_000002.12:127257732:G:A
NM_000122.2(ERCC3):c.2226G>A (p.Arg742=)	ERCC3		Xeroderma pigmentosum, complementation group b|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 20, 2018)	criteria provided, conflicting interpretations	VCV000710683	2	128015295	2	127257719	710683	719233	rs376593226	NC_000002.12:127257718:C:T
NM_000122.2(ERCC3):c.2218-5G>A	ERCC3		Xeroderma pigmentosum, complementation group b|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2018)	criteria provided, conflicting interpretations	VCV000695354	2	128015308	2	127257732	695354	685111	rs201054106	NC_000002.12:127257731:C:T
NM_000122.2(ERCC3):c.583C>T (p.Arg195Ter)	ERCC3	R195*, R131*	Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627443	2	128047339	2	127289763	627443	615785	rs138385061	NC_000002.12:127289762:G:A
NM_000122.2(ERCC3):c.658-7C>G	ERCC3		not provided|Xeroderma pigmentosum, complementation group b|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000512671	2	128047084	2	127289508	512671	498853	rs200361738	NC_000002.12:127289507:G:C
NM_000122.1(ERCC3):c.-69C>T	ERCC3		not provided|Xeroderma pigmentosum, complementation group b	Benign/Likely benign(Last reviewed: Jan 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000331098	2	128051726	2	127294150	331098	284284	rs9282675	NC_000002.12:127294149:G:A
NM_000122.2(ERCC3):c.-19C>T	ERCC3		Xeroderma pigmentosum, complementation group b	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331097	2	128051676	2	127294100	331097	284080	rs184301749	NC_000002.12:127294099:G:A
NM_000122.2(ERCC3):c.28+8G>A	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331096	2	128051622	2	127294046	331096	281800	rs886054844	NC_000002.12:127294045:C:T
NM_000122.2(ERCC3):c.29-15G>T	ERCC3		Xeroderma pigmentosum, complementation group b	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331095	2	128051309	2	127293733	331095	284281	rs188356418	NC_000002.12:127293732:C:A
NM_000122.2(ERCC3):c.254T>G (p.Phe85Cys)	ERCC3	F85C, F21C	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331094	2	128050403	2	127292827	331094	284279	rs767507847	NC_000002.12:127292826:A:C
NM_000122.2(ERCC3):c.359C>T (p.Ala120Val)	ERCC3	A120V, A56V	Trichothiodystrophy 2, photosensitive|Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Feb 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000331092	2	128050298	2	127292722	331092	284072	rs370115857	NC_000002.12:127292721:G:A
NM_000122.2(ERCC3):c.385G>A (p.Val129Ile)	ERCC3	V129I, V65I	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331091	2	128050272	2	127292696	331091	282429	rs145762413	NC_000002.12:127292695:C:T
NM_000122.2(ERCC3):c.615G>A (p.Glu205=)	ERCC3		Xeroderma pigmentosum, complementation group b|not provided	Benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000331090	2	128047307	2	127289731	331090	282427	rs13427563	NC_000002.12:127289730:C:T
NM_000122.2(ERCC3):c.618C>T (p.Ala206=)	ERCC3		not provided|Xeroderma pigmentosum, complementation group b	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000331089	2	128047304	2	127289728	331089	281798	rs145830873	NC_000002.12:127289727:G:A
NM_000122.2(ERCC3):c.657+15G>A	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000331088	2	128047250	2	127289674	331088	284070	rs781533251	NC_000002.12:127289673:C:T
NM_000122.2(ERCC3):c.822+14C>T	ERCC3		Xeroderma pigmentosum, complementation group b|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000331087	2	128046899	2	127289323	331087	284275	rs200833462	NC_000002.12:127289322:G:A
NM_000122.2(ERCC3):c.1026C>T (p.Cys342=)	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331086	2	128046237	2	127288661	331086	284255	rs752026166	NC_000002.12:127288660:G:A
NM_000122.2(ERCC3):c.1027+3A>G	ERCC3		Xeroderma pigmentosum, complementation group b|not provided	Benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000331085	2	128046233	2	127288657	331085	284244	rs4150417	NC_000002.12:127288656:T:C
NM_000122.2(ERCC3):c.1078C>T (p.Arg360Cys)	ERCC3	R360C, R296C	not provided|Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000331084	2	128044543	2	127286967	331084	284242	rs754010782	NC_000002.12:127286966:G:A
NM_000122.2(ERCC3):c.1119G>A (p.Gln373=)	ERCC3		Xeroderma pigmentosum, complementation group b|not provided	Benign(Last reviewed: Nov 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000331083	2	128044502	2	127286926	331083	282425	rs2228544	NC_000002.12:127286925:C:T
NM_000122.2(ERCC3):c.1155C>T (p.Asp385=)	ERCC3		not provided|Xeroderma pigmentosum, complementation group b	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2020)	criteria provided, conflicting interpretations	VCV000331082	2	128044466	2	127286890	331082	284240	rs371396764	NC_000002.12:127286889:G:A
NM_000122.2(ERCC3):c.1156G>A (p.Asp386Asn)	ERCC3	D386N, D322N	Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000331081	2	128044465	2	127286889	331081	284239	rs374264195	NC_000002.12:127286888:C:T
NM_000122.2(ERCC3):c.1371C>T (p.Ile457=)	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000331080	2	128038179	2	127280603	331080	284063	rs769083884	NC_000002.12:127280602:G:A
NM_000122.2(ERCC3):c.1485G>A (p.Glu495=)	ERCC3		not provided|Xeroderma pigmentosum, complementation group b	Benign/Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000331079	2	128038065	2	127280489	331079	284238	rs4150456	NC_000002.12:127280488:C:T
NM_000122.2(ERCC3):c.1731-11T>C	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000331078	2	128030548	2	127272972	331078	284236	rs746754189	NC_000002.12:127272971:A:G
NM_000122.2(ERCC3):c.1929G>T (p.Val643=)	ERCC3		Xeroderma pigmentosum, complementation group b|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000331077	2	128028928	2	127271352	331077	282424	rs375556869	NC_000002.12:127271351:C:A
NM_000122.2(ERCC3):c.2080G>A (p.Ala694Thr)	ERCC3	A694T, A630T	Xeroderma pigmentosum, complementation group b|not provided	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000331076	2	128017009	2	127259433	331076	284229	rs151216904	NC_000002.12:127259432:C:T
NM_000122.2(ERCC3):c.2106G>A (p.Ala702=)	ERCC3		Xeroderma pigmentosum, complementation group b	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000331074	2	128016983	2	127259407	331074	284221	rs114508982	NC_000002.12:127259406:C:T
NM_000122.2(ERCC3):c.2112G>A (p.Ser704=)	ERCC3		Xeroderma pigmentosum, complementation group b|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 13, 2018)	criteria provided, conflicting interpretations	VCV000331073	2	128016977	2	127259401	331073	281794	rs114710997	NC_000002.12:127259400:C:T
NM_000122.2(ERCC3):c.*29C>T	ERCC3		Xeroderma pigmentosum, complementation group b|not provided	Benign/Likely benign(Last reviewed: Apr 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000331072	2	128015143	2	127257567	331072	284047	rs4150523	NC_000002.12:127257566:G:A
NM_000122.2(ERCC3):c.*106T>C	ERCC3		Xeroderma pigmentosum, complementation group b|not provided	Likely benign(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000331071	2	128015066	2	127257490	331071	281793	rs4150524	NC_000002.12:127257489:A:G
NM_000122.2(ERCC3):c.*177A>G	ERCC3		Xeroderma pigmentosum, complementation group b	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000331070	2	128014995	2	127257419	331070	284042	rs4150525	NC_000002.12:127257418:T:C
NM_000122.2(ERCC3):c.*259G>A	ERCC3		not provided|Xeroderma pigmentosum, complementation group b	Benign(Last reviewed: Jan 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000331068	2	128014913	2	127257337	331068	282412	rs1803541	NC_000002.12:127257336:C:T
NM_000122.2(ERCC3):c.325C>T (p.Arg109Ter)	ERCC3	R109*, R45*	not provided|Xeroderma pigmentosum|Xeroderma pigmentosum, complementation group b	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000265515	2	128050332	2	127292756	265515	259693	rs34295337	NC_000002.12:127292755:G:A
NM_000122.2(ERCC3):c.847C>T (p.Arg283Cys)	ERCC3	R283C, R219C	Trichothiodystrophy 2, photosensitive|Xeroderma pigmentosum, complementation group b|not provided|not specified|Xeroderma pigmentosum, complementation group b|Trichothiodystrophy 2, photosensitive	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000134128	2	128046416	2	127288840	134128	137867	rs145201970	NC_000002.12:127288839:G:A
NM_000122.2(ERCC3):c.2111C>T (p.Ser704Leu)	ERCC3	S704L, S640L	not specified|not provided|Xeroderma pigmentosum, complementation group b	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2021)	criteria provided, conflicting interpretations	VCV000134120	2	128016978	2	127259402	134120	137859	rs4150521	NC_000002.12:127259401:G:A
NM_000122.2(ERCC3):c.471+1G>A	ERCC3		Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016589	2	128050185	2	127292609	16589	31628	rs1558964705	NC_000002.12:127292608:C:T
NM_000122.2(ERCC3):c.1633C>T (p.Gln545Ter)	ERCC3	Q545*, Q481*	Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016588	2	128036846	2	127279270	16588	31627	rs121913048	NC_000002.12:127279269:G:A
NM_000122.2(ERCC3):c.1273C>T (p.Arg425Ter)	ERCC3	R425*, R361*	Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016585	2	128044348	2	127286772	16585	31624	rs121913047	NC_000002.12:127286771:G:A
NM_000122.2(ERCC3):c.296T>C (p.Phe99Ser)	ERCC3	F99S, F35S	Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016583	2	128050361	2	127292785	16583	31622	rs121913045	NC_000002.12:127292784:A:G
ERCC3, IVS14AS, C-A, -6	ERCC3		Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016582					16582	31621		
NC_000016.9:g.14013666A>C	ERCC4		Fanconi anemia, complementation group Q|Cockayne syndrome|Xeroderma pigmentosum, group F	Benign(Last reviewed: Nov 21, 2020)	criteria provided, single submitter	VCV001164457	16	14013666	16	13919809	1164457	1157625		NC_000016.10:13919808:A:C
NM_005236.3(ERCC4):c.2619C>T (p.Ile873=)	ERCC4		Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Likely benign(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV001159467	16	14042072	16	13948215	1159467	1145791		NC_000016.10:13948214:C:T
NM_005236.3(ERCC4):c.1698G>A (p.Leu566=)	ERCC4		Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Likely benign(Last reviewed: Oct 10, 2019)	criteria provided, single submitter	VCV001149792	16	14029487	16	13935630	1149792	1145788		NC_000016.10:13935629:G:A
NM_005236.3(ERCC4):c.2223C>T (p.Leu741=)	ERCC4		Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: Jun 23, 2020)	criteria provided, single submitter	VCV001146409	16	14041676	16	13947819	1146409	1145790		NC_000016.10:13947818:C:T
NM_005236.3(ERCC4):c.15G>A (p.Gln5=)	ERCC4		Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV001146380	16	14014037	16	13920180	1146380	1145787		NC_000016.10:13920179:G:A
NM_005236.3(ERCC4):c.1971A>G (p.Val657=)	ERCC4		Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Likely benign(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001144287	16	14038646	16	13944789	1144287	1145789		NC_000016.10:13944788:A:G
NM_005236.3(ERCC4):c.2448G>A (p.Leu816=)	ERCC4		Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV001137949	16	14041901	16	13948044	1137949	1124918		NC_000016.10:13948043:G:A
NM_005236.3(ERCC4):c.2421T>C (p.His807=)	ERCC4		Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Likely benign(Last reviewed: Sep 16, 2020)	criteria provided, single submitter	VCV001132737	16	14041874	16	13948017	1132737	1124917		NC_000016.10:13948016:T:C
NM_005236.3(ERCC4):c.1214-4T>G	ERCC4		Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Likely benign(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV001132451	16	14028999	16	13935142	1132451	1124915		NC_000016.10:13935141:T:G
NM_005236.3(ERCC4):c.1320T>C (p.Phe440=)	ERCC4		Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Likely benign(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV001131874	16	14029109	16	13935252	1131874	1124916		NC_000016.10:13935251:T:C
NM_005236.3(ERCC4):c.2607C>T (p.His869=)	ERCC4		Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: Aug 10, 2020)	criteria provided, single submitter	VCV001122901	16	14042060	16	13948203	1122901	1124919		NC_000016.10:13948202:C:T
NM_005236.3(ERCC4):c.2394A>G (p.Leu798=)	ERCC4		Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Likely benign(Last reviewed: Mar 31, 2020)	criteria provided, single submitter	VCV001119821	16	14041847	16	13947990	1119821	1103509		NC_000016.10:13947989:A:G
NM_005236.3(ERCC4):c.1998C>T (p.Ser666=)	ERCC4		Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Likely benign(Last reviewed: Aug 24, 2019)	criteria provided, single submitter	VCV001117162	16	14038673	16	13944816	1117162	1103506		NC_000016.10:13944815:C:T
NM_005236.3(ERCC4):c.2265C>T (p.Pro755=)	ERCC4		Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Likely benign(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV001116433	16	14041718	16	13947861	1116433	1103508		NC_000016.10:13947860:C:T
NM_005236.3(ERCC4):c.2478G>A (p.Ala826=)	ERCC4		Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Likely benign(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV001116423	16	14041931	16	13948074	1116423	1103510		NC_000016.10:13948073:G:A
NM_005236.3(ERCC4):c.537A>G (p.Glu179=)	ERCC4		Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV001111141	16	14020566	16	13926709	1111141	1103503		NC_000016.10:13926708:A:G
NM_005236.3(ERCC4):c.132C>T (p.Leu44=)	ERCC4		Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV001107762	16	14014154	16	13920297	1107762	1103502		NC_000016.10:13920296:C:T
NM_005236.3(ERCC4):c.2124C>A (p.Pro708=)	ERCC4		Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV001107231	16	14041577	16	13947720	1107231	1103507		NC_000016.10:13947719:C:A
NM_005236.3(ERCC4):c.816T>A (p.Pro272=)	ERCC4		Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Likely benign(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV001107043	16	14024590	16	13930733	1107043	1103504		NC_000016.10:13930732:T:A
NM_005236.3(ERCC4):c.1102+7T>A	ERCC4		Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001101319	16	14026149	16	13932292	1101319	1103505		NC_000016.10:13932291:T:A
NM_005236.3(ERCC4):c.42G>A (p.Pro14=)	ERCC4		Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV001092737	16	14014064	16	13920207	1092737	1081674		NC_000016.10:13920206:G:A
NM_005236.3(ERCC4):c.1830C>T (p.Tyr610=)	ERCC4		Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: Jun 21, 2020)	criteria provided, single submitter	VCV001089716	16	14031641	16	13937784	1089716	1081676		NC_000016.10:13937783:C:T
NM_005236.3(ERCC4):c.2436G>A (p.Leu812=)	ERCC4		Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: Feb 23, 2019)	criteria provided, single submitter	VCV001087407	16	14041889	16	13948032	1087407	1081678		NC_000016.10:13948031:G:A
NM_005236.3(ERCC4):c.1258C>T (p.Leu420=)	ERCC4		Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Likely benign(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV001085451	16	14029047	16	13935190	1085451	1081675		NC_000016.10:13935189:C:T
NM_005236.3(ERCC4):c.2175G>A (p.Glu725=)	ERCC4		Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: Nov 28, 2019)	criteria provided, single submitter	VCV001079866	16	14041628	16	13947771	1079866	1081677		NC_000016.10:13947770:G:A
NM_005236.3(ERCC4):c.22C>T (p.Arg8Ter)	ERCC4	R8*	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Pathogenic(Last reviewed: Feb 5, 2020)	criteria provided, single submitter	VCV001075759	16	14014044	16	13920187	1075759	1063505		NC_000016.10:13920186:C:T
NM_005236.3(ERCC4):c.1102+1G>T	ERCC4		Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Likely pathogenic(Last reviewed: Mar 28, 2020)	criteria provided, single submitter	VCV001066740	16	14026143	16	13932286	1066740	1056287		NC_000016.10:13932285:G:T
NM_005236.3(ERCC4):c.1484C>T (p.Thr495Ile)	ERCC4	T495I	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001064260	16	14029273	16	13935416	1064260	1049323		NC_000016.10:13935415:C:T
NM_005236.3(ERCC4):c.782C>T (p.Pro261Leu)	ERCC4	P261L	Fanconi anemia, complementation group Q|Cockayne syndrome|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001062238	16	14022082	16	13928225	1062238	1049319		NC_000016.10:13928224:C:T
NM_005236.3(ERCC4):c.259C>T (p.Arg87Cys)	ERCC4	R87C	Fanconi anemia, complementation group Q|Cockayne syndrome|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Feb 7, 2020)	criteria provided, single submitter	VCV001060885	16	14015939	16	13922082	1060885	1049318		NC_000016.10:13922081:C:T
NM_005236.3(ERCC4):c.799C>T (p.Arg267Cys)	ERCC4	R267C	Fanconi anemia, complementation group Q|Cockayne syndrome|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV001060514	16	14024573	16	13930716	1060514	1049320		NC_000016.10:13930715:C:T
NM_005236.3(ERCC4):c.1031A>G (p.Tyr344Cys)	ERCC4	Y344C	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV001058221	16	14026071	16	13932214	1058221	1049322		NC_000016.10:13932213:A:G
NM_005236.3(ERCC4):c.1027G>A (p.Val343Ile)	ERCC4	V343I	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Aug 17, 2020)	criteria provided, single submitter	VCV001052787	16	14026067	16	13932210	1052787	1049321		NC_000016.10:13932209:G:A
NM_005236.3(ERCC4):c.1871G>A (p.Arg624Gln)	ERCC4	R624Q	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001052608	16	14031682	16	13937825	1052608	1049325		NC_000016.10:13937824:G:A
NM_005236.3(ERCC4):c.1799G>A (p.Gly600Glu)	ERCC4	G600E	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV001051747	16	14029588	16	13935731	1051747	1049324		NC_000016.10:13935730:G:A
NM_005236.3(ERCC4):c.124G>A (p.Asp42Asn)	ERCC4	D42N	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001045245	16	14014146	16	13920289	1045245	1032335		NC_000016.10:13920288:G:A
NM_005236.3(ERCC4):c.425C>A (p.Ser142Tyr)	ERCC4	S142Y	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Jul 1, 2020)	criteria provided, single submitter	VCV001044188	16	14020454	16	13926597	1044188	1032337		NC_000016.10:13926596:C:A
NM_005236.3(ERCC4):c.404G>A (p.Arg135Lys)	ERCC4	R135K	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Oct 25, 2020)	criteria provided, single submitter	VCV001043957	16	14020433	16	13926576	1043957	1032336		NC_000016.10:13926575:G:A
NM_005236.3(ERCC4):c.712A>G (p.Lys238Glu)	ERCC4	K238E	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV001041656	16	14022012	16	13928155	1041656	1032339		NC_000016.10:13928154:A:G
NM_005236.3(ERCC4):c.514G>C (p.Asp172His)	ERCC4	D172H	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Jun 18, 2020)	criteria provided, single submitter	VCV001039227	16	14020543	16	13926686	1039227	1032338		NC_000016.10:13926685:G:C
NM_005236.3(ERCC4):c.1336G>T (p.Ala446Ser)	ERCC4	A446S	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV001037862	16	14029125	16	13935268	1037862	1032340		NC_000016.10:13935267:G:T
NM_005236.3(ERCC4):c.1549G>A (p.Glu517Lys)	ERCC4	E517K	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Oct 25, 2020)	criteria provided, single submitter	VCV001037640	16	14029338	16	13935481	1037640	1032341		NC_000016.10:13935480:G:A
NM_005236.3(ERCC4):c.1975G>A (p.Gly659Ser)	ERCC4	G659S	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001034994	16	14038650	16	13944793	1034994	1032342		NC_000016.10:13944792:G:A
NM_005236.3(ERCC4):c.2308A>T (p.Thr770Ser)	ERCC4	T770S	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Jan 30, 2020)	criteria provided, single submitter	VCV001025296	16	14041761	16	13947904	1025296	1011833		NC_000016.10:13947903:A:T
NM_005236.3(ERCC4):c.1102G>A (p.Glu368Lys)	ERCC4	E368K	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001016989	16	14026142	16	13932285	1016989	1011831		NC_000016.10:13932284:G:A
NM_005236.3(ERCC4):c.1870C>A (p.Arg624=)	ERCC4		Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV001014952	16	14031681	16	13937824	1014952	1011832		NC_000016.10:13937823:C:A
NM_005236.3(ERCC4):c.1090A>G (p.Lys364Glu)	ERCC4	K364E	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Jan 20, 2018)	criteria provided, single submitter	VCV001010118	16	14026130	16	13932273	1010118	996591		NC_000016.10:13932272:A:G
NM_005236.3(ERCC4):c.326C>T (p.Ala109Val)	ERCC4	A109V	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Jun 14, 2020)	criteria provided, single submitter	VCV001009936	16	14016006	16	13922149	1009936	996587		NC_000016.10:13922148:C:T
NM_005236.3(ERCC4):c.913A>T (p.Thr305Ser)	ERCC4	T305S	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001008933	16	14024687	16	13930830	1008933	996589		NC_000016.10:13930829:A:T
NM_005236.3(ERCC4):c.2430G>A (p.Ala810=)	ERCC4		Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV001008644	16	14041883	16	13948026	1008644	996597		NC_000016.10:13948025:G:A
NM_005236.3(ERCC4):c.800G>T (p.Arg267Leu)	ERCC4	R267L	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001007763	16	14024574	16	13930717	1007763	996588		NC_000016.10:13930716:G:T
NM_005236.3(ERCC4):c.1243C>G (p.Arg415Gly)	ERCC4	R415G	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Apr 17, 2020)	criteria provided, single submitter	VCV001006484	16	14029032	16	13935175	1006484	996592		NC_000016.10:13935174:C:G
NM_005236.3(ERCC4):c.1870C>T (p.Arg624Trp)	ERCC4	R624W	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001005637	16	14031681	16	13937824	1005637	996596		NC_000016.10:13937823:C:T
NM_005236.3(ERCC4):c.1391A>T (p.Lys464Ile)	ERCC4	K464I	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Feb 7, 2018)	criteria provided, single submitter	VCV001003761	16	14029180	16	13935323	1003761	996593		NC_000016.10:13935322:A:T
NM_005236.3(ERCC4):c.1739T>C (p.Leu580Pro)	ERCC4	L580P	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001003655	16	14029528	16	13935671	1003655	996594		NC_000016.10:13935670:T:C
NM_005236.3(ERCC4):c.130C>T (p.Leu44Phe)	ERCC4	L44F	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Nov 1, 2020)	criteria provided, single submitter	VCV001002097	16	14014152	16	13920295	1002097	996586		NC_000016.10:13920294:C:T
NM_005236.3(ERCC4):c.947C>T (p.Thr316Met)	ERCC4	T316M	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Feb 29, 2020)	criteria provided, single submitter	VCV000998622	16	14024721	16	13930864	998622	996590		NC_000016.10:13930863:C:T
NM_005236.3(ERCC4):c.1802A>C (p.Lys601Thr)	ERCC4	K601T	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV000998517	16	14029591	16	13935734	998517	996595		NC_000016.10:13935733:A:C
NM_005236.3(ERCC4):c.1334A>C (p.Lys445Thr)	ERCC4	K445T	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV000972163	16	14029123	16	13935266	972163	957626		NC_000016.10:13935265:A:C
NM_005236.3(ERCC4):c.2017+3G>A	ERCC4		Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000970403	16	14038695	16	13944838	970403	960834		NC_000016.10:13944837:G:A
NM_005236.3(ERCC4):c.1201C>T (p.Leu401Phe)	ERCC4	L401F	Xeroderma pigmentosum, group F|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000967171	16	14028147	16	13934290	967171	957625		NC_000016.10:13934289:C:T
NM_005236.3(ERCC4):c.809T>C (p.Leu270Pro)	ERCC4	L270P	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000966101	16	14024583	16	13930726	966101	957624		NC_000016.10:13930725:T:C
NM_005236.3(ERCC4):c.991T>A (p.Ser331Thr)	ERCC4	S331T	Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: Aug 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000963460	16	14026031	16	13932174	963460	949164		NC_000016.10:13932173:T:A
NM_005236.3(ERCC4):c.2738A>G (p.Lys913Arg)	ERCC4	K913R	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000958705	16	14042191	16	13948334	958705	949167		NC_000016.10:13948333:A:G
NM_005236.3(ERCC4):c.1364A>G (p.Lys455Arg)	ERCC4	K455R	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV000955014	16	14029153	16	13935296	955014	949165		NC_000016.10:13935295:A:G
NM_005236.3(ERCC4):c.2101C>T (p.Arg701Cys)	ERCC4	R701C	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000953866	16	14041554	16	13947697	953866	949166		NC_000016.10:13947696:C:T
NM_005236.3(ERCC4):c.2620G>A (p.Ala874Thr)	ERCC4	A874T	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000950941	16	14042073	16	13948216	950941	927564		NC_000016.10:13948215:G:A
NM_005236.3(ERCC4):c.484A>G (p.Lys162Glu)	ERCC4	K162E	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV000949722	16	14020513	16	13926656	949722	927560		NC_000016.10:13926655:A:G
NM_005236.3(ERCC4):c.32C>T (p.Ala11Val)	ERCC4	A11V	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000948829	16	14014054	16	13920197	948829	927559		NC_000016.10:13920196:C:T
NM_005236.3(ERCC4):c.4G>C (p.Glu2Gln)	ERCC4	E2Q	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000947999	16	14014026	16	13920169	947999	927558		NC_000016.10:13920168:G:C
NM_005236.3(ERCC4):c.1648C>T (p.Pro550Ser)	ERCC4	P550S	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000946529	16	14029437	16	13935580	946529	927562		NC_000016.10:13935579:C:T
NM_005236.3(ERCC4):c.2575A>T (p.Asn859Tyr)	ERCC4	N859Y	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000945531	16	14042028	16	13948171	945531	927563		NC_000016.10:13948170:A:T
NM_005236.3(ERCC4):c.1114G>A (p.Glu372Lys)	ERCC4	E372K	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: May 27, 2019)	criteria provided, single submitter	VCV000944393	16	14028060	16	13934203	944393	927561		NC_000016.10:13934202:G:A
NM_005236.3(ERCC4):c.2546A>T (p.Gln849Leu)	ERCC4	Q849L	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV000943396	16	14041999	16	13948142	943396	937219		NC_000016.10:13948141:A:T
NM_005236.3(ERCC4):c.793-2A>G	ERCC4		Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000942911	16	14024565	16	13930708	942911	940343		NC_000016.10:13930707:A:G
NM_005236.3(ERCC4):c.2248C>T (p.Arg750Cys)	ERCC4	R750C	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome|Spastic ataxia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 4, 2021)	criteria provided, conflicting interpretations	VCV000941684	16	14041701	16	13947844	941684	937218		NC_000016.10:13947843:C:T
NM_005236.3(ERCC4):c.2621C>T (p.Ala874Val)	ERCC4	A874V	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV000938272	16	14042074	16	13948217	938272	937220		NC_000016.10:13948216:C:T
NM_005236.3(ERCC4):c.122C>G (p.Ala41Gly)	ERCC4	A41G	Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Uncertain significance(Last reviewed: May 18, 2019)	criteria provided, single submitter	VCV000933259	16	14014144	16	13920287	933259	937217		NC_000016.10:13920286:C:G
NM_005236.3(ERCC4):c.2178C>T (p.Arg726=)	ERCC4		Xeroderma pigmentosum, group F|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000888106	16	14041631	16	13947774	888106	874642		NC_000016.10:13947773:C:T
NM_005236.3(ERCC4):c.145C>T (p.Leu49Phe)	ERCC4	L49F	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q|not provided|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000884829	16	14014167	16	13920310	884829	874634		NC_000016.10:13920309:C:T
NM_005236.3(ERCC4):c.2290A>G (p.Ser764Gly)	ERCC4	S764G	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000864299	16	14041743	16	13947886	864299	843108		NC_000016.10:13947885:A:G
NM_005236.3(ERCC4):c.2735G>A (p.Gly912Glu)	ERCC4	G912E	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV000864275	16	14042188	16	13948331	864275	843112		NC_000016.10:13948330:G:A
NM_005236.3(ERCC4):c.934T>G (p.Ser312Ala)	ERCC4	S312A	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Feb 9, 2019)	criteria provided, single submitter	VCV000864133	16	14024708	16	13930851	864133	843097		NC_000016.10:13930850:T:G
NM_005236.3(ERCC4):c.1019G>A (p.Arg340Gln)	ERCC4	R340Q	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000861612	16	14026059	16	13932202	861612	843098		NC_000016.10:13932201:G:A
NM_005236.3(ERCC4):c.2212A>G (p.Asn738Asp)	ERCC4	N738D	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000861566	16	14041665	16	13947808	861566	843107		NC_000016.10:13947807:A:G
NM_005236.3(ERCC4):c.109C>T (p.Arg37Cys)	ERCC4	R37C	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000860287	16	14014131	16	13920274	860287	843094		NC_000016.10:13920273:C:T
NM_005236.3(ERCC4):c.751G>A (p.Asp251Asn)	ERCC4	D251N	Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Uncertain significance(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000858142	16	14022051	16	13928194	858142	843096		NC_000016.10:13928193:G:A
NM_005236.3(ERCC4):c.2102G>A (p.Arg701His)	ERCC4	R701H	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000858128	16	14041555	16	13947698	858128	843104		NC_000016.10:13947697:G:A
NM_005236.3(ERCC4):c.2588G>C (p.Cys863Ser)	ERCC4	C863S	Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Uncertain significance(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV000856803	16	14042041	16	13948184	856803	843111		NC_000016.10:13948183:G:C
NM_005236.3(ERCC4):c.1581A>T (p.Glu527Asp)	ERCC4	E527D	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Uncertain significance(Last reviewed: Sep 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000855799	16	14029370	16	13935513	855799	843100		NC_000016.10:13935512:A:T
NM_005236.3(ERCC4):c.2534A>G (p.Asn845Ser)	ERCC4	N845S	Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Uncertain significance(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000855385	16	14041987	16	13948130	855385	843110		NC_000016.10:13948129:A:G
NM_005236.3(ERCC4):c.26G>C (p.Arg9Pro)	ERCC4	R9P	Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Uncertain significance(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000854210	16	14014048	16	13920191	854210	843092		NC_000016.10:13920190:G:C
NM_005236.3(ERCC4):c.1684G>A (p.Asp562Asn)	ERCC4	D562N	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000853493	16	14029473	16	13935616	853493	843102		NC_000016.10:13935615:G:A
NM_005236.3(ERCC4):c.2474C>T (p.Ala825Val)	ERCC4	A825V	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000852153	16	14041927	16	13948070	852153	843109		NC_000016.10:13948069:C:T
NM_005236.3(ERCC4):c.37G>T (p.Ala13Ser)	ERCC4	A13S	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000852000	16	14014059	16	13920202	852000	843093		NC_000016.10:13920201:G:T
NM_005236.3(ERCC4):c.1304T>G (p.Leu435Arg)	ERCC4	L435R	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000851569	16	14029093	16	13935236	851569	843099		NC_000016.10:13935235:T:G
NM_005236.3(ERCC4):c.2176C>T (p.Arg726Cys)	ERCC4	R726C	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000843239	16	14041629	16	13947772	843239	843106		NC_000016.10:13947771:C:T
NM_005236.3(ERCC4):c.208-3T>C	ERCC4		Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000842159	16	14015885	16	13922028	842159	852620		NC_000016.10:13922027:T:C
NM_005236.3(ERCC4):c.1691A>G (p.Tyr564Cys)	ERCC4	Y564C	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000841845	16	14029480	16	13935623	841845	843103		NC_000016.10:13935622:A:G
NM_005236.3(ERCC4):c.1619C>T (p.Ser540Leu)	ERCC4	S540L	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000840996	16	14029408	16	13935551	840996	843101		NC_000016.10:13935550:C:T
NM_005236.3(ERCC4):c.389-9C>A	ERCC4		Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000838117	16	14020409	16	13926552	838117	851649		NC_000016.10:13926551:C:A
NM_005236.3(ERCC4):c.499A>G (p.Asn167Asp)	ERCC4	N167D	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000837122	16	14020528	16	13926671	837122	843095		NC_000016.10:13926670:A:G
NM_005236.3(ERCC4):c.2114A>T (p.Asp705Val)	ERCC4	D705V	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000835496	16	14041567	16	13947710	835496	843105		NC_000016.10:13947709:A:T
NM_005236.3(ERCC4):c.1001C>T (p.Ser334Leu)	ERCC4	S334L	not provided|Fanconi anemia, complementation group Q|Cockayne syndrome|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000810700	16	14026041	16	13932184	810700	797245	rs750883282	NC_000016.10:13932183:C:T
NM_005236.3(ERCC4):c.208-6A>G	ERCC4		not provided|Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV000792656	16	14015882	16	13922025	792656	787989	rs1596617926	NC_000016.10:13922024:A:G
NM_005236.3(ERCC4):c.924T>C (p.Asn308=)	ERCC4		Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV000737828	16	14024698	16	13930841	737828	754899	rs1408777193	NC_000016.10:13930840:T:C
NM_005236.3(ERCC4):c.1554A>C (p.Ile518=)	ERCC4		Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Likely benign(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV000733570	16	14029343	16	13935486	733570	739952	rs768020598	NC_000016.10:13935485:A:C
NM_005236.3(ERCC4):c.2647G>A (p.Glu883Lys)	ERCC4	E883K	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|not provided|Xeroderma pigmentosum, group F	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000697490	16	14042100	16	13948243	697490	688527	rs201652412	NC_000016.10:13948242:G:A
NM_005236.3(ERCC4):c.2700C>T (p.Phe900=)	ERCC4		Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV000696153	16	14042153	16	13948296	696153	684577	rs191674905	NC_000016.10:13948295:C:T
NM_005236.3(ERCC4):c.503C>T (p.Ala168Val)	ERCC4	A168V	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Fanconi anemia, complementation group Q	Conflicting interpretations of pathogenicity(Last reviewed: Jun 18, 2019)	criteria provided, conflicting interpretations	VCV000695963	16	14020532	16	13926675	695963	684573	rs2020961	NC_000016.10:13926674:C:T
NM_005236.3(ERCC4):c.738G>A (p.Ser246=)	ERCC4		Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV000695609	16	14022038	16	13928181	695609	684574	rs146650135	NC_000016.10:13928180:G:A
NM_005236.3(ERCC4):c.1347C>A (p.Val449=)	ERCC4		Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|not provided	Likely benign(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV000695568	16	14029136	16	13935279	695568	684575	rs1352012558	NC_000016.10:13935278:C:A
NM_005236.3(ERCC4):c.2169C>A (p.Cys723Ter)	ERCC4	C723*	Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome|not provided	Uncertain significance(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000664022	16	14041622	16	13947765	664022	643914	rs2020959	NC_000016.10:13947764:C:A
NM_005236.3(ERCC4):c.1787C>A (p.Ala596Glu)	ERCC4	A596E	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000662825	16	14029576	16	13935719	662825	643913	rs751782722	NC_000016.10:13935718:C:A
NM_005236.3(ERCC4):c.2177G>A (p.Arg726His)	ERCC4	R726H	Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Uncertain significance(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000658680	16	14041630	16	13947773	658680	643915	rs368096448	NC_000016.10:13947772:G:A
NM_005236.3(ERCC4):c.790A>G (p.Lys264Glu)	ERCC4	K264E	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000656025	16	14022090	16	13928233	656025	643910	rs1463126902	NC_000016.10:13928232:A:G
NM_005236.3(ERCC4):c.2423C>G (p.Ala808Gly)	ERCC4	A808G	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000655804	16	14041876	16	13948019	655804	643918	rs746576915	NC_000016.10:13948018:C:G
NM_005236.3(ERCC4):c.2295G>T (p.Lys765Asn)	ERCC4	K765N	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000653697	16	14041748	16	13947891	653697	643917	rs1567253853	NC_000016.10:13947890:G:T
NM_005236.3(ERCC4):c.1681A>T (p.Ser561Cys)	ERCC4	S561C	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000653625	16	14029470	16	13935613	653625	643912	rs1443581940	NC_000016.10:13935612:A:T
NM_005236.3(ERCC4):c.798C>G (p.Ile266Met)	ERCC4	I266M	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000652281	16	14024572	16	13930715	652281	643911	rs746106147	NC_000016.10:13930714:C:G
NM_005236.3(ERCC4):c.2186T>C (p.Ile729Thr)	ERCC4	I729T	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV000647874	16	14041639	16	13947782	647874	643916	rs375860375	NC_000016.10:13947781:T:C
NM_005236.3(ERCC4):c.257G>A (p.Arg86His)	ERCC4	R86H	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000647625	16	14015937	16	13922080	647625	643908	rs187435008	NC_000016.10:13922079:G:A
NM_005236.3(ERCC4):c.2603A>G (p.His868Arg)	ERCC4	H868R	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000646565	16	14042056	16	13948199	646565	643920	rs368064765	NC_000016.10:13948198:A:G
NM_005236.3(ERCC4):c.703G>A (p.Ala235Thr)	ERCC4	A235T	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000646508	16	14022003	16	13928146	646508	643909	rs141101671	NC_000016.10:13928145:G:A
NM_005236.3(ERCC4):c.2603A>C (p.His868Pro)	ERCC4	H868P	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Jun 26, 2020)	criteria provided, single submitter	VCV000645946	16	14042056	16	13948199	645946	643919	rs368064765	NC_000016.10:13948198:A:C
NM_005236.3(ERCC4):c.2725G>A (p.Val909Ile)	ERCC4	V909I	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|not provided|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Mar 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000642503	16	14042178	16	13948321	642503	643921	rs140726146	NC_000016.10:13948320:G:A
NM_005236.3(ERCC4):c.2677A>G (p.Asn893Asp)	ERCC4	N893D	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000579347	16	14042130	16	13948273	579347	567678	rs201926295	NC_000016.10:13948272:A:G
NM_005236.3(ERCC4):c.890A>G (p.Tyr297Cys)	ERCC4	Y297C	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000575691	16	14024664	16	13930807	575691	567677	rs996851583	NC_000016.10:13930806:A:G
NM_005236.3(ERCC4):c.1045G>A (p.Ala349Thr)	ERCC4	A349T	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000573650	16	14026085	16	13932228	573650	569972	rs201410515	NC_000016.10:13932227:G:A
NM_005236.3(ERCC4):c.2288C>T (p.Pro763Leu)	ERCC4	P763L	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV000569796	16	14041741	16	13947884	569796	569973	rs761087753	NC_000016.10:13947883:C:T
NM_005236.3(ERCC4):c.19G>A (p.Ala7Thr)	ERCC4	A7T	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Feb 22, 2020)	criteria provided, single submitter	VCV000568412	16	14014041	16	13920184	568412	573713	rs771117594	NC_000016.10:13920183:G:A
NM_005236.3(ERCC4):c.413G>A (p.Arg138Lys)	ERCC4	R138K	Fanconi anemia, complementation group Q|Cockayne syndrome|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000566287	16	14020442	16	13926585	566287	567671	rs1567243693	NC_000016.10:13926584:G:A
NM_005236.3(ERCC4):c.1983A>G (p.Ala661=)	ERCC4		Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000541253	16	14038658	16	13944801	541253	529772	rs373237850	NC_000016.10:13944800:A:G
NM_005236.3(ERCC4):c.1812-5T>C	ERCC4		Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Benign/Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000541252	16	14031618	16	13937761	541252	529444	rs2020952	NC_000016.10:13937760:T:C
NM_005236.3(ERCC4):c.1265A>T (p.Asp422Val)	ERCC4	D422V	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000541250	16	14029054	16	13935197	541250	529466	rs767408205	NC_000016.10:13935196:A:T
NM_005236.3(ERCC4):c.1633G>A (p.Gly545Arg)	ERCC4	G545R	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000541249	16	14029422	16	13935565	541249	529436	rs773007457	NC_000016.10:13935564:G:A
NM_005236.3(ERCC4):c.875G>A (p.Arg292Gln)	ERCC4	R292Q	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000541248	16	14024649	16	13930792	541248	529771	rs202243691	NC_000016.10:13930791:G:A
NM_005236.3(ERCC4):c.714G>A (p.Lys238=)	ERCC4		Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000541247	16	14022014	16	13928157	541247	529465	rs780166871	NC_000016.10:13928156:G:A
NM_005236.3(ERCC4):c.260G>A (p.Arg87His)	ERCC4	R87H	Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Uncertain significance(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000541246	16	14015940	16	13922083	541246	529434	rs371487368	NC_000016.10:13922082:G:A
NM_005236.3(ERCC4):c.2591G>A (p.Arg864His)	ERCC4	R864H	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Uncertain significance(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000541245	16	14042044	16	13948187	541245	529774	rs1211543560	NC_000016.10:13948186:G:A
NM_005236.3(ERCC4):c.532G>T (p.Val178Leu)	ERCC4	V178L	not provided|Xeroderma pigmentosum, group F|Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Aug 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000474207	16	14020561	16	13926704	474207	465053	rs149927607	NC_000016.10:13926703:G:T
NM_005236.3(ERCC4):c.325G>A (p.Ala109Thr)	ERCC4	A109T	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome|Xeroderma pigmentosum, group F|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2021)	criteria provided, conflicting interpretations	VCV000474205	16	14016005	16	13922148	474205	465045	rs148791570	NC_000016.10:13922147:G:A
NM_005236.3(ERCC4):c.228G>A (p.Leu76=)	ERCC4		Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000474204	16	14015908	16	13922051	474204	465041	rs61760162	NC_000016.10:13922050:G:A
NM_005236.3(ERCC4):c.2125G>A (p.Val709Met)	ERCC4	V709M	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000474203	16	14041578	16	13947721	474203	465919	rs373906926	NC_000016.10:13947720:G:A
NM_005236.3(ERCC4):c.1899C>G (p.Leu633=)	ERCC4		Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000474202	16	14031710	16	13937853	474202	465726	rs954215121	NC_000016.10:13937852:C:G
NM_005236.3(ERCC4):c.1123C>T (p.Leu375=)	ERCC4		Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome|not provided	Likely benign(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000474201	16	14028069	16	13934212	474201	465058	rs376695854	NC_000016.10:13934211:C:T
NM_005236.3(ERCC4):c.1031A>T (p.Tyr344Phe)	ERCC4	Y344F	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000474200	16	14026071	16	13932214	474200	465057	rs145851520	NC_000016.10:13932213:A:T
NM_005236.3(ERCC4):c.2427G>A (p.Thr809=)	ERCC4		not specified|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 9, 2017)	criteria provided, conflicting interpretations	VCV000435080	16	14041880	16	13948023	435080	429759	rs2020960	NC_000016.10:13948022:G:A
NM_005236.3(ERCC4):c.2046A>G (p.Gln682=)	ERCC4		not specified|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000435079	16	14041499	16	13947642	435079	429758	rs565249189	NC_000016.10:13947641:A:G
NM_005236.3(ERCC4):c.906T>C (p.Asp302=)	ERCC4		not specified|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Likely benign(Last reviewed: Jul 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000435077	16	14024680	16	13930823	435077	429756	rs148003381	NC_000016.10:13930822:T:C
NM_005236.3(ERCC4):c.2218C>T (p.Arg740Cys)	ERCC4	R740C	not provided|Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000425096	16	14041671	16	13947814	425096	413430	rs376688194	NC_000016.10:13947813:C:T
NM_005236.3(ERCC4):c.718C>T (p.Leu240=)	ERCC4		Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Likely benign(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV000415026	16	14022018	16	13928161	415026	400523	rs746904084	NC_000016.10:13928160:C:T
NM_005236.3(ERCC4):c.1446A>G (p.Glu482=)	ERCC4		Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000415025	16	14029235	16	13935378	415025	400529	rs114077770	NC_000016.10:13935377:A:G
NM_005236.3(ERCC4):c.389-5C>T	ERCC4		Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Benign(Last reviewed: Nov 26, 2020)	criteria provided, single submitter	VCV000415024	16	14020413	16	13926556	415024	400521	rs377224276	NC_000016.10:13926555:C:T
NM_005236.3(ERCC4):c.1899C>T (p.Leu633=)	ERCC4		not provided|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome	Likely benign(Last reviewed: Dec 24, 2016)	criteria provided, single submitter	VCV000415022	16	14031710	16	13937853	415022	401357	rs954215121	NC_000016.10:13937852:C:T
NM_005236.3(ERCC4):c.1677T>C (p.Gly559=)	ERCC4		Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Likely benign(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000415021	16	14029466	16	13935609	415021	400667	rs776049363	NC_000016.10:13935608:T:C
NM_005236.3(ERCC4):c.41C>T (p.Pro14Leu)	ERCC4	P14L	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000408565	16	14014063	16	13920206	408565	401098	rs754622238	NC_000016.10:13920205:C:T
NM_005236.3(ERCC4):c.1212A>G (p.Pro404=)	ERCC4		Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000408564	16	14028158	16	13934301	408564	401337	rs752193295	NC_000016.10:13934300:A:G
NM_005236.3(ERCC4):c.889T>A (p.Tyr297Asn)	ERCC4	Y297N	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Nov 4, 2016)	criteria provided, single submitter	VCV000408563	16	14024663	16	13930806	408563	401100	rs778480216	NC_000016.10:13930805:T:A
NM_005236.3(ERCC4):c.241G>A (p.Val81Ile)	ERCC4	V81I	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Aug 15, 2020)	criteria provided, single submitter	VCV000408562	16	14015921	16	13922064	408562	400665	rs55761944	NC_000016.10:13922063:G:A
NM_005236.3(ERCC4):c.2292C>T (p.Ser764=)	ERCC4		Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome|Xeroderma pigmentosum, group F	Conflicting interpretations of pathogenicity(Last reviewed: Nov 10, 2020)	criteria provided, conflicting interpretations	VCV000317821	16	14041745	16	13947888	317821	341879	rs139406689	NC_000016.10:13947887:C:T
NM_005236.3(ERCC4):c.1884A>G (p.Glu628=)	ERCC4		Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome|Xeroderma pigmentosum, group F	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000317817	16	14031695	16	13937838	317817	341877	rs2020958	NC_000016.10:13937837:A:G
NM_005236.3(ERCC4):c.1728A>T (p.Arg576Ser)	ERCC4	R576S	Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Jun 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000317816	16	14029517	16	13935660	317816	341868	rs765454246	NC_000016.10:13935659:A:T
NM_005236.3(ERCC4):c.1676G>A (p.Gly559Asp)	ERCC4	G559D	Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000317815	16	14029465	16	13935608	317815	340492	rs370896187	NC_000016.10:13935607:G:A
NM_005236.3(ERCC4):c.1284G>A (p.Ala428=)	ERCC4		Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome|Xeroderma pigmentosum, group F	Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2020)	criteria provided, conflicting interpretations	VCV000317811	16	14029073	16	13935216	317811	333738	rs3136151	NC_000016.10:13935215:G:A
NM_005236.3(ERCC4):c.61C>G (p.Gln21Glu)	ERCC4	Q21E	Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Jul 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000317797	16	14014083	16	13920226	317797	340484	rs748499820	NC_000016.10:13920225:C:G
NM_005236.3(ERCC4):c.974-7G>A	ERCC4		Fanconi anemia, complementation group Q|not specified|not provided|Xeroderma pigmentosum, group F|XFE progeroid syndrome|Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000259686	16	14026007	16	13932150	259686	255455	rs254942	NC_000016.10:13932149:G:A
NM_005236.3(ERCC4):c.2724C>T (p.Val908=)	ERCC4		not specified|Xeroderma pigmentosum, group F|not provided|Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Benign/Likely benign(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000259685	16	14042177	16	13948320	259685	255457	rs3136225	NC_000016.10:13948319:C:T
NM_005236.3(ERCC4):c.2655G>A (p.Thr885=)	ERCC4		not specified|not provided|Xeroderma pigmentosum, group F|Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000259684	16	14042108	16	13948251	259684	255456	rs16963255	NC_000016.10:13948250:G:A
NM_005236.3(ERCC4):c.503C>G (p.Ala168Gly)	ERCC4	A168G	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Fanconi anemia, complementation group Q	Uncertain significance(Last reviewed: Jul 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000240126	16	14020532	16	13926675	240126	242191	rs2020961	NC_000016.10:13926674:C:G
NM_005236.3(ERCC4):c.33C>T (p.Ala11=)	ERCC4		Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q|not specified|Xeroderma pigmentosum, group F|not provided	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000240125	16	14014055	16	13920198	240125	242189	rs3136042	NC_000016.10:13920197:C:T
NM_005236.3(ERCC4):c.252C>T (p.Leu84=)	ERCC4		not specified|not provided|Xeroderma pigmentosum, group F|Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Benign/Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000240124	16	14015932	16	13922075	240124	242190	rs3136056	NC_000016.10:13922074:C:T
NM_005236.3(ERCC4):c.2463A>G (p.Pro821=)	ERCC4		Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000240123	16	14041916	16	13948059	240123	242192	rs2020953	NC_000016.10:13948058:A:G
NM_005236.3(ERCC4):c.974-6T>C	ERCC4		not specified|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome|Xeroderma pigmentosum, group F	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218668	16	14026008	16	13932151	218668	215505	rs201181735	NC_000016.10:13932150:T:C
NM_005236.3(ERCC4):c.1727G>C (p.Arg576Thr)	ERCC4	R576T	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|not provided|Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|not specified	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000134158	16	14029516	16	13935659	134158	137897	rs1800068	NC_000016.10:13935658:G:C
NM_005236.3(ERCC4):c.1244G>A (p.Arg415Gln)	ERCC4	R415Q	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Xeroderma pigmentosum, group F|not provided|not specified	Benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000134155	16	14029033	16	13935176	134155	137894	rs1800067	NC_000016.10:13935175:G:A
NM_005236.3(ERCC4):c.1563C>G (p.Ser521Arg)	ERCC4	S521R	not provided|Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|XFE progeroid syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000134153	16	14029352	16	13935495	134153	137892	rs41552412	NC_000016.10:13935494:C:G
NM_005236.3(ERCC4):c.1415C>T (p.Pro472Leu)	ERCC4	P472L	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Fanconi anemia, complementation group Q|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000134152	16	14029204	16	13935347	134152	137891	rs572439259	NC_000016.10:13935346:C:T
NM_005236.3(ERCC4):c.1488A>T (p.Gln496His)	ERCC4	Q496H	Hutchinson-Gilford syndrome|Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|not specified|Xeroderma pigmentosum, group F	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000134150	16	14029277	16	13935420	134150	137889	rs146601373	NC_000016.10:13935419:A:T
NM_005236.3(ERCC4):c.1135C>T (p.Pro379Ser)	ERCC4	P379S	not provided|Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Xeroderma pigmentosum, group F|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000134148	16	14028081	16	13934224	134148	137887	rs1799802	NC_000016.10:13934223:C:T
NM_005236.3(ERCC4):c.211T>C (p.Tyr71His)	ERCC4	Y71H	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|not specified|not provided	Uncertain significance(Last reviewed: Jun 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000134145	16	14015891	16	13922034	134145	137884	rs145315496	NC_000016.10:13922033:T:C
NM_005236.3(ERCC4):c.241G>T (p.Val81Phe)	ERCC4	V81F	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|not specified	Benign(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000134144	16	14015921	16	13922064	134144	137883	rs55761944	NC_000016.10:13922063:G:T
NM_005236.3(ERCC4):c.217A>G (p.Ile73Val)	ERCC4	I73V	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|not specified|not provided|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000134143	16	14015897	16	13922040	134143	137882	rs141591400	NC_000016.10:13922039:A:G
NM_005236.3(ERCC4):c.2117T>C (p.Ile706Thr)	ERCC4	I706T	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Xeroderma pigmentosum, group F|not specified|XFE progeroid syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000134142	16	14041570	16	13947713	134142	137881	rs1800069	NC_000016.10:13947712:T:C
NM_005236.3(ERCC4):c.2734G>A (p.Gly912Arg)	ERCC4	G912R	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|not specified|not provided	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, single submitter	VCV000134141	16	14042187	16	13948330	134141	137880	rs150077735	NC_000016.10:13948329:G:A
NM_005236.3(ERCC4):c.2579C>A (p.Ala860Asp)	ERCC4	A860D	Hutchinson-Gilford syndrome|Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|not specified|Xeroderma pigmentosum, group F	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000134138	16	14042032	16	13948175	134138	137877	rs4986933	NC_000016.10:13948174:C:A
NM_005236.3(ERCC4):c.2545C>G (p.Gln849Glu)	ERCC4	Q849E	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|not specified	Likely benign(Last reviewed: Nov 5, 2020)	criteria provided, single submitter	VCV000134137	16	14041998	16	13948141	134137	137876	rs374186605	NC_000016.10:13948140:C:G
NM_005236.3(ERCC4):c.2477C>T (p.Ala826Val)	ERCC4	A826V	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|not specified	Uncertain significance(Last reviewed: Feb 3, 2020)	criteria provided, single submitter	VCV000134136	16	14041930	16	13948073	134136	137875	rs141790888	NC_000016.10:13948072:C:T
NM_005236.3(ERCC4):c.2617A>G (p.Ile873Val)	ERCC4	I873V	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|not provided|not specified|Xeroderma pigmentosum, group F	Benign/Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000134135	16	14042070	16	13948213	134135	137874	rs2020957	NC_000016.10:13948212:A:G
NM_005236.3(ERCC4):c.1984T>C (p.Ser662Pro)	ERCC4	S662P	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Xeroderma pigmentosum, group F|not specified|not provided	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000134134	16	14038659	16	13944802	134134	137873	rs2020955	NC_000016.10:13944801:T:C
NM_005236.3(ERCC4):c.79C>T (p.Leu27Phe)	ERCC4	L27F	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|not specified|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Mar 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000134132	16	14014101	16	13920244	134132	137871	rs587778282	NC_000016.10:13920243:C:T
NM_005236.3(ERCC4):c.16C>T (p.Pro6Ser)	ERCC4	P6S	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|not provided|not specified	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000134131	16	14014038	16	13920181	134131	137870	rs61760160	NC_000016.10:13920180:C:T
NM_005236.3(ERCC4):c.2624A>G (p.Glu875Gly)	ERCC4	E875G	Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Cockayne syndrome|Xeroderma pigmentosum, group F|not provided|Hereditary cancer-predisposing syndrome|not specified	Benign/Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000129008	16	14042077	16	13948220	129008	134454	rs1800124	NC_000016.10:13948219:A:G
NM_005236.3(ERCC4):c.2505T>C (p.Ser835=)	ERCC4		XFE progeroid syndrome|Fanconi anemia, complementation group Q|not specified|not provided|Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Xeroderma pigmentosum, group F	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000129007	16	14041958	16	13948101	129007	134453	rs1799801	NC_000016.10:13948100:T:C
NM_005236.3(ERCC4):c.1765C>T (p.Arg589Trp)	ERCC4	R589W	Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|XFE progeroid syndrome|Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Xeroderma pigmentosum, type F/Cockayne syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000055829	16	14029554	16	13935697	55829	70487	rs147105770	NC_000016.10:13935696:C:T
NM_005236.3(ERCC4):c.706T>C (p.Cys236Arg)	ERCC4	C236R	Xeroderma pigmentosum, type F/Cockayne syndrome|not provided	Likely pathogenic(Last reviewed: Jun 16, 2021)	criteria provided, single submitter	VCV000055827	16	14022006	16	13928149	55827	70485	rs397509403	NC_000016.10:13928148:T:C
NM_005236.3(ERCC4):c.2065C>A (p.Arg689Ser)	ERCC4	R689S	Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Likely pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000055824	16	14041518	16	13947661	55824	70482	rs149364215	NC_000016.10:13947660:C:A
NM_005236.3(ERCC4):c.2395C>T (p.Arg799Trp)	ERCC4	R799W	Hutchinson-Gilford syndrome|Breast carcinoma|Xeroderma pigmentosum, group F|Carcinoma of pancreas|Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|XFE progeroid syndrome|Xeroderma pigmentosum, group F|XFE progeroid syndrome|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000016580	16	14041848	16	13947991	16580	31619	rs121913049	NC_000016.10:13947990:C:T
NM_000123.4(ERCC5):c.526C>T (p.Gln176Ter)	ERCC5|BIVM-ERCC5	Q176*, Q630*	Xeroderma pigmentosum group g/Cockayne syndrome	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000016571	13	103508460	13	102856110	16571	31610	rs121434573	NC_000013.11:102856109:C:T
NM_000124.4(ERCC6):c.652G>A (p.Glu218Lys)	ERCC6|ERCC6-PGBD3	E218K	Cockayne syndrome B	Uncertain significance(Last reviewed: Jun 23, 2021)	criteria provided, single submitter	VCV001299433	10	50736463	10	49528417	1299433	1289380		NC_000010.11:49528416:C:T
NM_000124.4(ERCC6):c.2382+33T>C	ERCC6		Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|UV-sensitive syndrome 1|not provided	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV001226200	10	50684228	10	49476182	1226200	1214879		NC_000010.11:49476181:A:G
NM_000124.4(ERCC6):c.2286+1G>T	ERCC6		not provided	Pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001074056	10	50686399	10	49478353	1074056	1061908		NC_000010.11:49478352:C:A
NM_000124.4(ERCC6):c.1690G>T (p.Glu564Ter)	ERCC6	E564*	not provided	Pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001070425	10	50701294	10	49493248	1070425	1061911		NC_000010.11:49493247:C:A
NM_000124.4(ERCC6):c.[1727C>G;1834C>T]	ERCC6	R612*, T576R	Cerebrooculofacioskeletal syndrome 1	Pathogenic(Last reviewed: May 31, 2019)	no assertion criteria provided	VCV000998032	10|10	50691550	10|10	49483504	998032	421792|985743	rs376526037	NC_000010.11:49483503:G:A|NC_000010.11:49493210:G:C
NM_000124.4(ERCC6):c.3757G>T (p.Glu1253Ter)	ERCC6	E1253*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Apr 23, 2019)	no assertion criteria provided	VCV000984252	10	50678249	10	49470203	984252	972077		NC_000010.11:49470202:C:A
NM_000124.4(ERCC6):c.574C>T (p.Gln192Ter)	ERCC6|ERCC6-PGBD3	Q192*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Dec 4, 2019)	no assertion criteria provided	VCV000984141	10	50736541	10	49528495	984141	972098		NC_000010.11:49528494:G:A
NM_000124.4(ERCC6):c.1516A>T (p.Lys506Ter)	ERCC6	K506*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Jul 6, 2019)	no assertion criteria provided	VCV000984140	10	50713940	10	49505894	984140	972097		NC_000010.11:49505893:T:A
NM_000124.4(ERCC6):c.1777A>T (p.Arg593Ter)	ERCC6	R593*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Dec 28, 2019)	no assertion criteria provided	VCV000984139	10	50701207	10	49493161	984139	972096		NC_000010.11:49493160:T:A
NM_000124.4(ERCC6):c.1816A>T (p.Lys606Ter)	ERCC6	K606*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Feb 5, 2019)	no assertion criteria provided	VCV000984138	10	50701168	10	49493122	984138	972095		NC_000010.11:49493121:T:A
NM_000124.4(ERCC6):c.2201T>G (p.Leu734Ter)	ERCC6	L734*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Dec 6, 2019)	no assertion criteria provided	VCV000984137	10	50686485	10	49478439	984137	972094		NC_000010.11:49478438:A:C
NM_000124.4(ERCC6):c.2380C>T (p.Gln794Ter)	ERCC6	Q794*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Sep 7, 2019)	no assertion criteria provided	VCV000983771	10	50684263	10	49476217	983771	972093		NC_000010.11:49476216:G:A
NM_000124.4(ERCC6):c.2504G>A (p.Trp835Ter)	ERCC6	W835*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Mar 31, 2019)	no assertion criteria provided	VCV000983770	10	50682167	10	49474121	983770	972092		NC_000010.11:49474120:C:T
NM_000124.4(ERCC6):c.2543T>A (p.Leu848Ter)	ERCC6	L848*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000983769	10	50682128	10	49474082	983769	972091		NC_000010.11:49474081:A:T
NM_000124.4(ERCC6):c.2566C>T (p.Gln856Ter)	ERCC6	Q856*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Mar 5, 2020)	no assertion criteria provided	VCV000983768	10	50682105	10	49474059	983768	972090		NC_000010.11:49474058:G:A
NM_000124.4(ERCC6):c.2807G>A (p.Trp936Ter)	ERCC6	W936*	Cockayne syndrome B	Likely pathogenic(Last reviewed: May 7, 2019)	no assertion criteria provided	VCV000983767	10	50680977	10	49472931	983767	972089		NC_000010.11:49472930:C:T
NM_000124.4(ERCC6):c.2846G>A (p.Trp949Ter)	ERCC6	W949*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Dec 4, 2019)	no assertion criteria provided	VCV000983766	10	50680500	10	49472454	983766	972088		NC_000010.11:49472453:C:T
NM_000124.4(ERCC6):c.3007G>T (p.Glu1003Ter)	ERCC6	E1003*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Dec 15, 2019)	no assertion criteria provided	VCV000983765	10	50679084	10	49471038	983765	972087		NC_000010.11:49471037:C:A
NM_000124.4(ERCC6):c.3070G>T (p.Gly1024Ter)	ERCC6	G1024*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Dec 23, 2019)	no assertion criteria provided	VCV000983764	10	50679021	10	49470975	983764	972086		NC_000010.11:49470974:C:A
NM_000124.4(ERCC6):c.3097A>T (p.Lys1033Ter)	ERCC6	K1033*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Dec 27, 2019)	no assertion criteria provided	VCV000983691	10	50678909	10	49470863	983691	972085		NC_000010.11:49470862:T:A
NM_000124.4(ERCC6):c.3355G>T (p.Glu1119Ter)	ERCC6	E1119*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Jun 28, 2019)	no assertion criteria provided	VCV000983690	10	50678651	10	49470605	983690	972084		NC_000010.11:49470604:C:A
NM_000124.4(ERCC6):c.3448A>T (p.Lys1150Ter)	ERCC6	K1150*	Cockayne syndrome B	Likely pathogenic(Last reviewed: May 31, 2019)	no assertion criteria provided	VCV000983689	10	50678558	10	49470512	983689	972083		NC_000010.11:49470511:T:A
NM_000124.4(ERCC6):c.3465C>A (p.Tyr1155Ter)	ERCC6	Y1155*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Mar 3, 2020)	no assertion criteria provided	VCV000983688	10	50678541	10	49470495	983688	972082		NC_000010.11:49470494:G:T
NM_000124.4(ERCC6):c.3544A>T (p.Lys1182Ter)	ERCC6	K1182*	Cockayne syndrome B	Likely pathogenic(Last reviewed: May 1, 2019)	no assertion criteria provided	VCV000983687	10	50678462	10	49470416	983687	972081		NC_000010.11:49470415:T:A
NM_000124.4(ERCC6):c.3574G>T (p.Glu1192Ter)	ERCC6	E1192*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Apr 27, 2019)	no assertion criteria provided	VCV000983686	10	50678432	10	49470386	983686	972080		NC_000010.11:49470385:C:A
NM_000124.4(ERCC6):c.3637A>T (p.Arg1213Ter)	ERCC6	R1213*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000983685	10	50678369	10	49470323	983685	972079		NC_000010.11:49470322:T:A
NM_000124.4(ERCC6):c.3655G>T (p.Gly1219Ter)	ERCC6	G1219*	Cockayne syndrome B	Likely pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000983684	10	50678351	10	49470305	983684	972078		NC_000010.11:49470304:C:A
NM_000124.4(ERCC6):c.1997G>A (p.Arg666His)	ERCC6	R666H	Cockayne syndrome	Uncertain significance(Last reviewed: Aug 19, 2020)	criteria provided, single submitter	VCV000982246	10	50690905	10	49482859	982246	970356		NC_000010.11:49482858:C:T
NM_000124.4(ERCC6):c.543+1G>T	ERCC6|ERCC6-PGBD3		Cockayne syndrome B	Likely pathogenic	criteria provided, single submitter	VCV000974894	10	50738765	10	49530719	974894	963154		NC_000010.11:49530718:C:A
NM_000124.4(ERCC6):c.3661C>T (p.Arg1221Ter)	ERCC6	R1221*	not provided	Pathogenic(Last reviewed: Sep 7, 2019)	criteria provided, single submitter	VCV000957191	10	50678345	10	49470299	957191	946922		NC_000010.11:49470298:G:A
NM_000124.4(ERCC6):c.1686-12G>A	ERCC6		Age-related macular degeneration 5|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000880492	10	50701310	10	49493264	880492	868475		NC_000010.11:49493263:C:T
NM_000124.4(ERCC6):c.3901C>T (p.Arg1301Cys)	ERCC6	R1301C	Age-related macular degeneration 5|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000880168	10	50669480	10	49461434	880168	865941		NC_000010.11:49461433:G:A
NM_000124.4(ERCC6):c.*246T>C	ERCC6		Age-related macular degeneration 5|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000880064	10	50666615	10	49458569	880064	865933		NC_000010.11:49458568:A:G
NM_000124.4(ERCC6):c.*2540G>T	ERCC6		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000879860	10	50664321	10	49456275	879860	865926		NC_000010.11:49456274:C:A
NM_000124.4(ERCC6):c.*2602A>G	ERCC6		Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000879859	10	50664259	10	49456213	879859	865925		NC_000010.11:49456212:T:C
NM_000124.4(ERCC6):c.*3356C>T	ERCC6		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000879814	10	50663505	10	49455459	879814	865916		NC_000010.11:49455458:G:A
NM_000124.4(ERCC6):c.*3366G>A	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000879813	10	50663495	10	49455449	879813	865915		NC_000010.11:49455448:C:T
NM_000124.4(ERCC6):c.*4208A>G	ERCC6		Age-related macular degeneration 5|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000879771	10	50662653	10	49454607	879771	865905		NC_000010.11:49454606:T:C
NM_000124.4(ERCC6):c.*813C>T	ERCC6		Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000879644	10	50666048	10	49458002	879644	865931		NC_000010.11:49458001:G:A
NM_000124.4(ERCC6):c.*2031A>G	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000879544	10	50664830	10	49456784	879544	865928		NC_000010.11:49456783:T:C
NM_000124.4(ERCC6):c.*2662T>C	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000879497	10	50664199	10	49456153	879497	865924		NC_000010.11:49456152:A:G
NM_000124.4(ERCC6):c.*2680A>C	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000879496	10	50664181	10	49456135	879496	865923		NC_000010.11:49456134:T:G
NM_000124.4(ERCC6):c.431C>T (p.Thr144Met)	ERCC6|ERCC6-PGBD3	T144M	Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000879447	10	50738878	10	49530832	879447	865952		NC_000010.11:49530831:G:A
NM_000124.4(ERCC6):c.*3395A>C	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000879446	10	50663466	10	49455420	879446	865914		NC_000010.11:49455419:T:G
NM_000124.4(ERCC6):c.*3684A>G	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000879445	10	50663177	10	49455131	879445	865913		NC_000010.11:49455130:T:C
NM_000124.4(ERCC6):c.*3704C>T	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000879444	10	50663157	10	49455111	879444	865912		NC_000010.11:49455110:G:A
NM_000124.4(ERCC6):c.2081C>T (p.Pro694Leu)	ERCC6	P694L	not provided|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Uncertain significance(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000879261	10	50690821	10	49482775	879261	865947		NC_000010.11:49482774:G:A
NM_000124.4(ERCC6):c.2776G>C (p.Ala926Pro)	ERCC6	A926P	Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000879154	10	50681008	10	49472962	879154	865945		NC_000010.11:49472961:C:G
NM_000124.4(ERCC6):c.4295G>A (p.Arg1432Lys)	ERCC6	R1432K	Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000878900	10	50667048	10	49459002	878900	865936		NC_000010.11:49459001:C:T
NM_000124.4(ERCC6):c.4306G>A (p.Ala1436Thr)	ERCC6	A1436T	Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000878899	10	50667037	10	49458991	878899	865935		NC_000010.11:49458990:C:T
NM_000124.4(ERCC6):c.2204G>T (p.Arg735Leu)	ERCC6	R735L	Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000878660	10	50686482	10	49478436	878660	865946		NC_000010.11:49478435:C:A
NM_000124.4(ERCC6):c.3764T>C (p.Leu1255Pro)	ERCC6	L1255P	Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000878410	10	50678242	10	49470196	878410	865943		NC_000010.11:49470195:A:G
NM_000124.4(ERCC6):c.3983+4A>G	ERCC6		Age-related macular degeneration 5|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000878360	10	50669394	10	49461348	878360	868473		NC_000010.11:49461347:T:C
NM_000124.4(ERCC6):c.4041A>G (p.Thr1347=)	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000878359	10	50668440	10	49460394	878359	865939		NC_000010.11:49460393:T:C
NM_000124.4(ERCC6):c.4067G>A (p.Gly1356Asp)	ERCC6	G1356D	Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000878358	10	50667276	10	49459230	878358	865938		NC_000010.11:49459229:C:T
NM_000124.4(ERCC6):c.4430A>G (p.His1477Arg)	ERCC6	H1477R	Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000878316	10	50666913	10	49458867	878316	865934		NC_000010.11:49458866:T:C
NM_000124.4(ERCC6):c.*922C>T	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000878193	10	50665939	10	49457893	878193	865930		NC_000010.11:49457892:G:A
NM_000124.4(ERCC6):c.-65G>A	ERCC6|ERCC6-PGBD3		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000878085	10	50747058	10	49539012	878085	865954		NC_000010.11:49539011:C:T
NM_000124.4(ERCC6):c.*2729G>A	ERCC6		Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000878035	10	50664132	10	49456086	878035	865922		NC_000010.11:49456085:C:T
NM_000124.4(ERCC6):c.*2766T>G	ERCC6		Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000878034	10	50664095	10	49456049	878034	865921		NC_000010.11:49456048:A:C
NM_000124.4(ERCC6):c.*2946C>T	ERCC6		Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000878033	10	50663915	10	49455869	878033	865920		NC_000010.11:49455868:G:A
NM_000124.4(ERCC6):c.*3720T>C	ERCC6		Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000877984	10	50663141	10	49455095	877984	865911		NC_000010.11:49455094:A:G
NM_000124.4(ERCC6):c.*3823T>C	ERCC6		Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000877983	10	50663038	10	49454992	877983	865910		NC_000010.11:49454991:A:G
NM_000124.4(ERCC6):c.*3921A>G	ERCC6		Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000877982	10	50662940	10	49454894	877982	865909		NC_000010.11:49454893:T:C
NM_000124.4(ERCC6):c.-32G>A	ERCC6|ERCC6-PGBD3		Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000877919	10	50747025	10	49538979	877919	865953		NC_000010.11:49538978:C:T
NM_000124.4(ERCC6):c.*2460T>C	ERCC6		Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000877918	10	50664401	10	49456355	877918	865927		NC_000010.11:49456354:A:G
NM_000124.4(ERCC6):c.*2973C>G	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000877872	10	50663888	10	49455842	877872	865919		NC_000010.11:49455841:G:C
NM_000124.4(ERCC6):c.*3217T>G	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000877871	10	50663644	10	49455598	877871	865918		NC_000010.11:49455597:A:C
NM_000124.4(ERCC6):c.*3280A>G	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000877870	10	50663581	10	49455535	877870	865917		NC_000010.11:49455534:T:C
NM_000124.4(ERCC6):c.814G>A (p.Glu272Lys)	ERCC6|ERCC6-PGBD3	E272K	Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Genetic non-acquired premature ovarian failure	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000877820	10	50732662	10	49524616	877820	865951		NC_000010.11:49524615:C:T
NM_000124.4(ERCC6):c.*3925A>G	ERCC6		Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000877819	10	50662936	10	49454890	877819	865908		NC_000010.11:49454889:T:C
NM_000124.4(ERCC6):c.*4019A>G	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000877818	10	50662842	10	49454796	877818	865907		NC_000010.11:49454795:T:C
NM_000124.4(ERCC6):c.*4090G>A	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000877817	10	50662771	10	49454725	877817	865906		NC_000010.11:49454724:C:T
NM_000124.4(ERCC6):c.1993-12T>C	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000877687	10	50690921	10	49482875	877687	868474		NC_000010.11:49482874:A:G
NM_000124.4(ERCC6):c.3123A>G (p.Gln1041=)	ERCC6		Cerebrooculofacioskeletal syndrome 1|not provided|Age-related macular degeneration 5|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000877491	10	50678883	10	49470837	877491	865944		NC_000010.11:49470836:T:C
NM_000124.4(ERCC6):c.3892A>G (p.Arg1298Gly)	ERCC6	R1298G	Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000877387	10	50669489	10	49461443	877387	865942		NC_000010.11:49461442:T:C
NM_000124.4(ERCC6):c.4216G>A (p.Glu1406Lys)	ERCC6	E1406K	Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|not provided	Uncertain significance(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000877330	10	50667127	10	49459081	877330	865937		NC_000010.11:49459080:C:T
NM_000124.4(ERCC6):c.*589A>G	ERCC6		Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000877211	10	50666272	10	49458226	877211	865932		NC_000010.11:49458225:T:C
NM_000124.4(ERCC6):c.*1805G>T	ERCC6		Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000877095	10	50665056	10	49457010	877095	865929		NC_000010.11:49457009:C:A
NM_000124.4(ERCC6):c.1607T>G (p.Leu536Trp)	ERCC6	L536W	not provided	Pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV000858140	10	50708662	10	49500616	858140	836915		NC_000010.11:49500615:A:C
NM_000124.4(ERCC6):c.1919G>A (p.Trp640Ter)	ERCC6	W640*	not provided|Cockayne syndrome B	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000857492	10	50691465	10	49483419	857492	836913		NC_000010.11:49483418:C:T
NM_000124.4(ERCC6):c.2143G>T (p.Gly715Ter)	ERCC6	G715*	not provided	Pathogenic(Last reviewed: Jun 20, 2020)	criteria provided, single submitter	VCV000856377	10	50690759	10	49482713	856377	836912		NC_000010.11:49482712:C:A
NM_000124.4(ERCC6):c.2709+1G>T	ERCC6		not provided	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000847342	10	50681522	10	49473476	847342	852252		NC_000010.11:49473475:C:A
NM_000124.4(ERCC6):c.653-2A>G	ERCC6|ERCC6-PGBD3		not provided	Likely pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000841744	10	50732825	10	49524779	841744	851774		NC_000010.11:49524778:T:C
NM_000124.4(ERCC6):c.2925-8T>A	ERCC6		not provided|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5	Conflicting interpretations of pathogenicity(Last reviewed: Dec 1, 2020)	criteria provided, conflicting interpretations	VCV000727959	10	50679174	10	49471128	727959	744510	rs147637331	NC_000010.11:49471127:A:T
NM_000124.4(ERCC6):c.-15+3G>T	ERCC6|ERCC6-PGBD3		Cockayne syndrome B	Likely pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000692034	10	50747005	10	49538959	692034	679828	rs1010201937	NC_000010.11:49538958:C:A
NM_000124.4(ERCC6):c.3942G>A (p.Trp1314Ter)	ERCC6	W1314*	Cockayne syndrome B	Pathogenic	no assertion criteria provided	VCV000598738	10	50669439	10	49461393	598738	589799	rs1564725764	NC_000010.11:49461392:C:T
NM_000124.4(ERCC6):c.1390C>T (p.Arg464Trp)	ERCC6|ERCC6-PGBD3|PGBD3	R464W	not provided|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000595151	10	50732086	10	49524040	595151	586213	rs375995821	NC_000010.11:49524039:G:A
NM_000124.4(ERCC6):c.1681T>G (p.Tyr561Asp)	ERCC6	Y561D	Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1	Uncertain significance(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587485	10	50708588	10	49500542	587485	578484	rs1564430115	NC_000010.11:49500541:A:C
NM_000124.4(ERCC6):c.1527-2A>G	ERCC6		Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cockayne syndrome B	Likely pathogenic(Last reviewed: Jun 3, 2018)	criteria provided, single submitter	VCV000558660	10	50708744	10	49500698	558660	545081	rs768608345	NC_000010.11:49500697:T:C
NM_000124.4(ERCC6):c.2383-1G>A	ERCC6		Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cockayne syndrome B	Likely pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000558051	10	50682289	10	49474243	558051	545066	rs1554787554	NC_000010.11:49474242:C:T
NM_000124.4(ERCC6):c.2560C>T (p.Gln854Ter)	ERCC6	Q854*	Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cockayne syndrome B	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000557733	10	50682111	10	49474065	557733	545403	rs1554787509	NC_000010.11:49474064:G:A
NM_000124.4(ERCC6):c.4062+2T>A	ERCC6		Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cockayne syndrome B	Likely pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000556731	10	50668417	10	49460371	556731	545054	rs1554873950	NC_000010.11:49460370:A:T
NM_000124.4(ERCC6):c.422+1G>C	ERCC6|ERCC6-PGBD3		not provided|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1	Likely pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556340	10	50740588	10	49532542	556340	545708	rs1198472093	NC_000010.11:49532541:C:G
NM_000124.4(ERCC6):c.3778+1G>C	ERCC6		Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cockayne syndrome B	Likely pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000555653	10	50678227	10	49470181	555653	545062	rs1554875114	NC_000010.11:49470180:C:G
NM_000124.4(ERCC6):c.1821+1G>A	ERCC6		not provided|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000555221	10	50701162	10	49493116	555221	545689	rs1228919836	NC_000010.11:49493115:C:T
NM_000124.4(ERCC6):c.1135G>T (p.Glu379Ter)	ERCC6|ERCC6-PGBD3	E379*	not provided|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555146	10	50732341	10	49524295	555146	545703	rs1554793270	NC_000010.11:49524294:C:A
NM_000124.4(ERCC6):c.1595A>G (p.Asp532Gly)	ERCC6	D532G	DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Nov 12, 2017)	criteria provided, single submitter	VCV000555033	10	50708674	10	49500628	555033	545695	rs752712823	NC_000010.11:49500627:T:C
NM_000124.4(ERCC6):c.1398-2A>G	ERCC6		not provided|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1	Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554946	10	50714060	10	49506014	554946	545454	rs1317145066	NC_000010.11:49506013:T:C
NM_000124.4(ERCC6):c.2169+1G>A	ERCC6		DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Likely pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000554803	10	50690732	10	49482686	554803	545412	rs1441655600	NC_000010.11:49482685:C:T
NM_000124.4(ERCC6):c.3984-2A>G	ERCC6		DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Likely pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000554470	10	50668499	10	49460453	554470	545670	rs1554873973	NC_000010.11:49460452:T:C
NM_000124.4(ERCC6):c.4399C>T (p.Arg1467Ter)	ERCC6	R1467*	DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Likely pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000554231	10	50666944	10	49458898	554231	545669	rs762976316	NC_000010.11:49458897:G:A
NM_000124.4(ERCC6):c.544-2A>G	ERCC6|ERCC6-PGBD3		DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000553815	10	50736573	10	49528527	553815	545429	rs1554794073	NC_000010.11:49528526:T:C
NM_000124.4(ERCC6):c.2829+1G>A	ERCC6		DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Likely pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000553712	10	50680954	10	49472908	553712	545064	rs1554875522	NC_000010.11:49472907:C:T
NM_000124.4(ERCC6):c.2569C>T (p.Arg857Ter)	ERCC6	R857*	Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|not provided	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553383	10	50682102	10	49474056	553383	545446	rs751448793	NC_000010.11:49474055:G:A
NM_000124.4(ERCC6):c.2060C>T (p.Ser687Leu)	ERCC6	S687L	Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000552600	10	50690842	10	49482796	552600	545422	rs1026438103	NC_000010.11:49482795:G:A
NM_000124.4(ERCC6):c.1062T>A (p.Pro354=)	ERCC6|ERCC6-PGBD3		DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Likely benign(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000552306	10	50732414	10	49524368	552306	545472	rs764159237	NC_000010.11:49524367:A:T
NM_000124.4(ERCC6):c.3071-1G>A	ERCC6		DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Likely pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000551813	10	50678936	10	49470890	551813	545400	rs1554875287	NC_000010.11:49470889:C:T
NM_000124.4(ERCC6):c.-14-2A>G	ERCC6|ERCC6-PGBD3		DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000551705	10	50741026	10	49532980	551705	545437	rs760663515	NC_000010.11:49532979:T:C
NM_000124.4(ERCC6):c.526C>T (p.Arg176Ter)	ERCC6|ERCC6-PGBD3	R176*	Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000551532	10	50738783	10	49530737	551532	545474	rs771781694	NC_000010.11:49530736:G:A
NM_000124.4(ERCC6):c.2287-2A>G	ERCC6		Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1	Likely pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000551374	10	50684358	10	49476312	551374	545449	rs754978734	NC_000010.11:49476311:T:C
NM_000124.4(ERCC6):c.1009A>T (p.Lys337Ter)	ERCC6|ERCC6-PGBD3	K337*	not provided|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Pathogenic/Likely pathogenic(Last reviewed: Feb 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000550722	10	50732467	10	49524421	550722	545084	rs1198241866	NC_000010.11:49524420:T:A
NM_000124.4(ERCC6):c.422+1G>A	ERCC6|ERCC6-PGBD3		not provided|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1	Likely pathogenic(Last reviewed: May 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000550687	10	50740588	10	49532542	550687	545092	rs1198472093	NC_000010.11:49532541:C:T
NM_000124.4(ERCC6):c.4382C>G (p.Ser1461Ter)	ERCC6	S1461*	Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2017)	criteria provided, single submitter	VCV000550686	10	50666961	10	49458915	550686	545050	rs1554873743	NC_000010.11:49458914:G:C
NM_000124.4(ERCC6):c.2286+1G>A	ERCC6		Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1	Likely pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000550657	10	50686399	10	49478353	550657	545452	rs1362935450	NC_000010.11:49478352:C:T
NM_000124.4(ERCC6):c.184G>A (p.Ala62Thr)	ERCC6|ERCC6-PGBD3	A62T	Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1	Uncertain significance(Last reviewed: Jan 3, 2017)	criteria provided, single submitter	VCV000550120	10	50740827	10	49532781	550120	545434	rs186839348	NC_000010.11:49532780:C:T
NM_000124.4(ERCC6):c.2038A>G (p.Asn680Asp)	ERCC6	N680D	Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1	Uncertain significance(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000550065	10	50690864	10	49482818	550065	545427	rs1554788393	NC_000010.11:49482817:T:C
NM_000124.4(ERCC6):c.4063-1G>C	ERCC6		not provided|Cockayne syndrome B|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000549960	10	50667281	10	49459235	549960	545387	rs766980240	NC_000010.11:49459234:C:G
NM_000124.4(ERCC6):c.2551T>A (p.Trp851Arg)	ERCC6	W851R	Cockayne syndrome B	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000522698	10	50682120	10	49474074	522698	513306	rs368728467	NC_000010.11:49474073:A:T
NM_000124.4(ERCC6):c.2839C>T (p.Arg947Ter)	ERCC6	R947*	DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000502165	10	50680507	10	49472461	502165	493589	rs906755254	NC_000010.11:49472460:G:A
NM_000124.4(ERCC6):c.1820A>G (p.Lys607Arg)	ERCC6	K607R	Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2019)	criteria provided, conflicting interpretations	VCV000452965	10	50701164	10	49493118	452965	444606	rs200832611	NC_000010.11:49493117:T:C
NM_000124.4(ERCC6):c.4063-2A>C	ERCC6		not provided	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000452964	10	50667282	10	49459236	452964	444605	rs1554873833	NC_000010.11:49459235:T:G
NM_000124.4(ERCC6):c.2875G>T (p.Val959Leu)	ERCC6	V959L	Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|not provided	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000445943	10	50680471	10	49472425	445943	439215	rs190863815	NC_000010.11:49472424:C:A
NM_000124.4(ERCC6):c.2058G>A (p.Trp686Ter)	ERCC6	W686*	Cockayne syndrome B	Pathogenic(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	VCV000435083	10	50690844	10	49482798	435083	429067	rs751292948	NC_000010.11:49482797:C:T
NM_000124.4(ERCC6):c.2923C>T (p.Arg975Ter)	ERCC6	R975*	Cockayne syndrome B|not provided	Pathogenic(Last reviewed: Mar 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000435082	10	50680423	10	49472377	435082	429066	rs772801089	NC_000010.11:49472376:G:A
NM_000124.4(ERCC6):c.1834C>T (p.Arg612Ter)	ERCC6	R612*	DE SANCTIS-CACCHIONE SYNDROME|Inborn genetic diseases|not provided|DE SANCTIS-CACCHIONE SYNDROME|Premature ovarian failure 11|Cerebrooculofacioskeletal syndrome 1|Lung carcinoma|UV-sensitive syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000430298	10	50691550	10	49483504	430298	421792	rs376526037	NC_000010.11:49483503:G:A
NM_000124.4(ERCC6):c.1589T>C (p.Leu530Pro)	ERCC6	L530P	Cerebrooculofacioskeletal syndrome 1|not provided|Cockayne syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 9, 2019)	criteria provided, conflicting interpretations	VCV000374116	10	50708680	10	49500634	374116	360919	rs1057518910	NC_000010.11:49500633:A:G
NM_000124.4(ERCC6):c.-107A>G	ERCC6|ERCC6-PGBD3		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000300103	10	50747100	10	49539054	300103	321589	rs886047042	NC_000010.11:49539053:T:C
NM_000124.4(ERCC6):c.-100A>G	ERCC6|ERCC6-PGBD3		Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000300102	10	50747093	10	49539047	300102	315584	rs886047041	NC_000010.11:49539046:T:C
NM_000124.4(ERCC6):c.-87C>A	ERCC6|ERCC6-PGBD3		not provided|Macular degeneration|Cockayne syndrome|COFS syndrome	Benign(Last reviewed: May 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000300101	10	50747080	10	49539034	300101	310463	rs4253004	NC_000010.11:49539033:G:T
NM_000124.4(ERCC6):c.-83G>A	ERCC6|ERCC6-PGBD3		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300100	10	50747076	10	49539030	300100	310460	rs886047040	NC_000010.11:49539029:C:T
NM_000124.4(ERCC6):c.-78G>T	ERCC6|ERCC6-PGBD3		not provided|Cockayne syndrome|Macular degeneration|COFS syndrome	Benign(Last reviewed: May 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000300099	10	50747071	10	49539025	300099	321588	rs4253005	NC_000010.11:49539024:C:A
NM_000124.4(ERCC6):c.-52G>A	ERCC6|ERCC6-PGBD3		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000300098	10	50747045	10	49538999	300098	322344	rs550772412	NC_000010.11:49538998:C:T
NM_000124.4(ERCC6):c.-22G>A	ERCC6|ERCC6-PGBD3		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000300097	10	50747015	10	49538969	300097	322340	rs4253006	NC_000010.11:49538968:C:T
NM_000124.4(ERCC6):c.-15+11G>A	ERCC6|ERCC6-PGBD3		Macular degeneration|Cockayne syndrome|COFS syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300096	10	50746997	10	49538951	300096	322331	rs766986601	NC_000010.11:49538950:C:T
NM_000124.4(ERCC6):c.379G>A (p.Val127Ile)	ERCC6|ERCC6-PGBD3	V127I	Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|not provided	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000300095	10	50740632	10	49532586	300095	321586	rs116275562	NC_000010.11:49532585:C:T
NM_000124.4(ERCC6):c.595C>G (p.Leu199Val)	ERCC6|ERCC6-PGBD3	L199V	Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000300093	10	50736520	10	49528474	300093	321580	rs886047039	NC_000010.11:49528473:G:C
NM_000124.4(ERCC6):c.858G>C (p.Lys286Asn)	ERCC6|ERCC6-PGBD3	K286N	not provided|Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)	criteria provided, conflicting interpretations	VCV000300092	10	50732618	10	49524572	300092	321577	rs143260457	NC_000010.11:49524571:C:G
NM_000124.4(ERCC6):c.901C>T (p.Pro301Ser)	ERCC6|ERCC6-PGBD3	P301S	Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300091	10	50732575	10	49524529	300091	322330	rs766256094	NC_000010.11:49524528:G:A
NM_000124.4(ERCC6):c.1062T>C (p.Pro354=)	ERCC6|ERCC6-PGBD3		not provided|Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Sep 15, 2020)	criteria provided, conflicting interpretations	VCV000300090	10	50732414	10	49524368	300090	315583	rs764159237	NC_000010.11:49524367:A:G
NM_000124.4(ERCC6):c.1146G>A (p.Glu382=)	ERCC6|ERCC6-PGBD3		not provided|Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Benign/Likely benign(Last reviewed: Apr 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000300089	10	50732330	10	49524284	300089	315580	rs4253045	NC_000010.11:49524283:C:T
NM_000124.4(ERCC6):c.1158C>A (p.Asp386Glu)	ERCC6|ERCC6-PGBD3|PGBD3	D386E	Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000300088	10	50732318	10	49524272	300088	315579	rs141391984	NC_000010.11:49524271:G:T
NM_000124.4(ERCC6):c.1158C>G (p.Asp386Glu)	ERCC6|ERCC6-PGBD3|PGBD3	D386E	not specified|not provided|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000300087	10	50732318	10	49524272	300087	321576	rs141391984	NC_000010.11:49524271:G:C
NM_000124.4(ERCC6):c.1158C>T (p.Asp386=)	ERCC6|ERCC6-PGBD3|PGBD3		Cerebrooculofacioskeletal syndrome 1|not provided|Cockayne syndrome B|Age-related macular degeneration 5	Conflicting interpretations of pathogenicity(Last reviewed: Sep 11, 2018)	criteria provided, conflicting interpretations	VCV000300086	10	50732318	10	49524272	300086	315577	rs141391984	NC_000010.11:49524271:G:A
NM_000124.4(ERCC6):c.1159G>A (p.Glu387Lys)	ERCC6|ERCC6-PGBD3|PGBD3	E387K	Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|not provided|Age-related macular degeneration 5	Conflicting interpretations of pathogenicity(Last reviewed: Oct 31, 2020)	criteria provided, conflicting interpretations	VCV000300085	10	50732317	10	49524271	300085	310457	rs148295935	NC_000010.11:49524270:C:T
NM_000124.4(ERCC6):c.1229G>A (p.Gly410Asp)	ERCC6|ERCC6-PGBD3|PGBD3	G410D	Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|not provided|Age-related macular degeneration 5	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000300084	10	50732247	10	49524201	300084	310456	rs138865542	NC_000010.11:49524200:C:T
NM_000124.4(ERCC6):c.1280T>C (p.Phe427Ser)	ERCC6|ERCC6-PGBD3|PGBD3	F427S	Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000300082	10	50732196	10	49524150	300082	310452	rs886047038	NC_000010.11:49524149:A:G
NM_000124.4(ERCC6):c.1435C>T (p.Arg479Cys)	ERCC6	R479C	Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000300080	10	50714021	10	49505975	300080	310450	rs61749175	NC_000010.11:49505974:G:A
NM_000124.4(ERCC6):c.1436G>A (p.Arg479His)	ERCC6	R479H	Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|not provided|Cockayne syndrome B	Uncertain significance(Last reviewed: Mar 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000300079	10	50714020	10	49505974	300079	321569	rs139161933	NC_000010.11:49505973:C:T
NM_000124.4(ERCC6):c.1482C>T (p.Asp494=)	ERCC6		not provided|Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2020)	criteria provided, conflicting interpretations	VCV000300078	10	50713974	10	49505928	300078	310447	rs150762517	NC_000010.11:49505927:G:A
NM_000124.4(ERCC6):c.1760C>T (p.Thr587Met)	ERCC6	T587M	Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|not provided|Age-related macular degeneration 5	Conflicting interpretations of pathogenicity(Last reviewed: Oct 9, 2020)	criteria provided, conflicting interpretations	VCV000300077	10	50701224	10	49493178	300077	322324	rs767709344	NC_000010.11:49493177:G:A
NM_000124.4(ERCC6):c.1761G>T (p.Thr587=)	ERCC6		Age-related macular degeneration 5|not provided|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2020)	criteria provided, conflicting interpretations	VCV000300076	10	50701223	10	49493177	300076	322323	rs144608959	NC_000010.11:49493176:C:A
NM_000124.4(ERCC6):c.1992+7C>T	ERCC6		Cerebrooculofacioskeletal syndrome 1|not provided|Age-related macular degeneration 5|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Nov 23, 2020)	criteria provided, conflicting interpretations	VCV000300075	10	50691385	10	49483339	300075	315576	rs373710355	NC_000010.11:49483338:G:A
NM_000124.4(ERCC6):c.2022T>A (p.Ser674=)	ERCC6		not provided|Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000300074	10	50690880	10	49482834	300074	315571	rs544471829	NC_000010.11:49482833:A:T
NM_000124.4(ERCC6):c.2125G>A (p.Val709Ile)	ERCC6	V709I	Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Apr 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000300073	10	50690777	10	49482731	300073	321568	rs369437807	NC_000010.11:49482730:C:T
NM_000124.4(ERCC6):c.2287-5C>T	ERCC6		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|not provided|Age-related macular degeneration 5	Conflicting interpretations of pathogenicity(Last reviewed: Aug 9, 2020)	criteria provided, conflicting interpretations	VCV000300072	10	50684361	10	49476315	300072	322318	rs772880581	NC_000010.11:49476314:G:A
NM_000124.4(ERCC6):c.2287-4G>A	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2020)	criteria provided, conflicting interpretations	VCV000300071	10	50684360	10	49476314	300071	310439	rs375617750	NC_000010.11:49476313:C:T
NM_000124.4(ERCC6):c.2287-3T>C	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300070	10	50684359	10	49476313	300070	310437	rs780652533	NC_000010.11:49476312:A:G
NM_000124.4(ERCC6):c.2337C>T (p.Phe779=)	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)	criteria provided, conflicting interpretations	VCV000300069	10	50684306	10	49476260	300069	315570	rs114490473	NC_000010.11:49476259:G:A
NM_000124.4(ERCC6):c.2365C>G (p.Leu789Val)	ERCC6	L789V	Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300068	10	50684278	10	49476232	300068	322317	rs139913322	NC_000010.11:49476231:G:C
NM_000124.4(ERCC6):c.2390C>G (p.Ser797Cys)	ERCC6	S797C	Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|not provided|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Apr 11, 2019)	criteria provided, conflicting interpretations	VCV000300067	10	50682281	10	49474235	300067	321566	rs146043988	NC_000010.11:49474234:G:C
NM_000124.4(ERCC6):c.2391C>T (p.Ser797=)	ERCC6		not provided|Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)	criteria provided, conflicting interpretations	VCV000300066	10	50682280	10	49474234	300066	321563	rs142641602	NC_000010.11:49474233:G:A
NM_000124.4(ERCC6):c.2397T>C (p.Leu799=)	ERCC6		Age-related macular degeneration 5|not provided|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000300065	10	50682274	10	49474228	300065	315556	rs200079929	NC_000010.11:49474227:A:G
NM_000124.4(ERCC6):c.2598+7G>A	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|not provided|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2019)	criteria provided, conflicting interpretations	VCV000300063	10	50682066	10	49474020	300063	321558	rs769421755	NC_000010.11:49474019:C:T
NM_000124.4(ERCC6):c.2645A>G (p.Tyr882Cys)	ERCC6	Y882C	Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300062	10	50681587	10	49473541	300062	322308	rs116431130	NC_000010.11:49473540:T:C
NM_000124.4(ERCC6):c.2696C>T (p.Thr899Met)	ERCC6	T899M	Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1	Uncertain significance(Last reviewed: Sep 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000300061	10	50681536	10	49473490	300061	322307	rs374470147	NC_000010.11:49473489:G:A
NM_000124.4(ERCC6):c.2697G>A (p.Thr899=)	ERCC6		not provided|Macular degeneration|Cockayne syndrome|COFS syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 15, 2020)	criteria provided, conflicting interpretations	VCV000300060	10	50681535	10	49473489	300060	315555	rs761802751	NC_000010.11:49473488:C:T
NM_000124.4(ERCC6):c.2741C>T (p.Thr914Met)	ERCC6	T914M	Age-related macular degeneration 5|none provided|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Jul 4, 2020)	criteria provided, conflicting interpretations	VCV000300059	10	50681043	10	49472997	300059	315554	rs142580756	NC_000010.11:49472996:G:A
NM_000124.4(ERCC6):c.2829+11A>T	ERCC6		Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300058	10	50680944	10	49472898	300058	310435	rs777251839	NC_000010.11:49472897:T:A
NM_000124.4(ERCC6):c.2905G>A (p.Glu969Lys)	ERCC6	E969K	Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300057	10	50680441	10	49472395	300057	310434	rs886047035	NC_000010.11:49472394:C:T
NM_000124.4(ERCC6):c.2974C>G (p.Gln992Glu)	ERCC6	Q992E	DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000300056	10	50679117	10	49471071	300056	315553	rs772104945	NC_000010.11:49471070:G:C
NM_000124.4(ERCC6):c.2989A>G (p.Lys997Glu)	ERCC6	K997E	Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Uncertain significance(Last reviewed: Apr 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000300055	10	50679102	10	49471056	300055	321557	rs375181157	NC_000010.11:49471055:T:C
NM_000124.4(ERCC6):c.2996A>G (p.Asn999Ser)	ERCC6	N999S	Cockayne syndrome B|Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000300054	10	50679095	10	49471049	300054	310428	rs760694729	NC_000010.11:49471048:T:C
NM_000124.4(ERCC6):c.3186T>C (p.Ser1062=)	ERCC6		Cockayne syndrome|not provided|Macular degeneration|COFS syndrome	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000300053	10	50678820	10	49470774	300053	321549	rs35365613	NC_000010.11:49470773:A:G
NM_000124.4(ERCC6):c.3191A>G (p.Asn1064Ser)	ERCC6	N1064S	Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000300052	10	50678815	10	49470769	300052	315552	rs200093886	NC_000010.11:49470768:T:C
NM_000124.4(ERCC6):c.3391A>G (p.Asn1131Asp)	ERCC6	N1131D	Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|not provided|Age-related macular degeneration 5	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2020)	criteria provided, conflicting interpretations	VCV000300051	10	50678615	10	49470569	300051	310424	rs147079519	NC_000010.11:49470568:T:C
NM_000124.4(ERCC6):c.3453A>G (p.Leu1151=)	ERCC6		Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000300050	10	50678553	10	49470507	300050	310422	rs771604820	NC_000010.11:49470506:T:C
NM_000124.4(ERCC6):c.3456T>G (p.Gly1152=)	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|not provided	Benign/Likely benign(Last reviewed: Mar 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000300049	10	50678550	10	49470504	300049	321548	rs148366188	NC_000010.11:49470503:A:C
NM_000124.4(ERCC6):c.3480C>G (p.Pro1160=)	ERCC6		Age-related macular degeneration 5|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000300048	10	50678526	10	49470480	300048	321541	rs886047034	NC_000010.11:49470479:G:C
NM_000124.4(ERCC6):c.3481A>C (p.Ser1161Arg)	ERCC6	S1161R	Age-related macular degeneration 5|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|not provided	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000300047	10	50678525	10	49470479	300047	322306	rs142094044	NC_000010.11:49470478:T:G
NM_000124.4(ERCC6):c.3482G>C (p.Ser1161Thr)	ERCC6	S1161T	Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|not provided|Age-related macular degeneration 5	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000300046	10	50678524	10	49470478	300046	315551	rs148636026	NC_000010.11:49470477:C:G
NM_000124.4(ERCC6):c.3594A>G (p.Lys1198=)	ERCC6		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 22, 2020)	criteria provided, conflicting interpretations	VCV000300045	10	50678412	10	49470366	300045	321540	rs374791168	NC_000010.11:49470365:T:C
NM_000124.4(ERCC6):c.3636C>T (p.Cys1212=)	ERCC6		Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|not provided|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Mar 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000300044	10	50678370	10	49470324	300044	310417	rs886047033	NC_000010.11:49470323:G:A
NM_000124.4(ERCC6):c.3774A>G (p.Lys1258=)	ERCC6		Age-related macular degeneration 5|not provided|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000300043	10	50678232	10	49470186	300043	321522	rs35756610	NC_000010.11:49470185:T:C
NM_000124.4(ERCC6):c.3804C>T (p.His1268=)	ERCC6		Age-related macular degeneration 5|not provided|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)	criteria provided, conflicting interpretations	VCV000300042	10	50669577	10	49461531	300042	315546	rs116032070	NC_000010.11:49461530:G:A
NM_000124.4(ERCC6):c.3922G>C (p.Val1308Leu)	ERCC6	V1308L	not specified|not provided|Macular degeneration|Cockayne syndrome|COFS syndrome	Benign/Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000300041	10	50669459	10	49461413	300041	310414	rs2229761	NC_000010.11:49461412:C:G
NM_000124.4(ERCC6):c.3965G>T (p.Gly1322Val)	ERCC6	G1322V	Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5|not provided	Benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000300040	10	50669416	10	49461370	300040	315545	rs4253219	NC_000010.11:49461369:C:A
NM_000124.4(ERCC6):c.4114G>A (p.Gly1372Arg)	ERCC6	G1372R	Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|not provided	Benign/Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000300039	10	50667229	10	49459183	300039	322303	rs4253227	NC_000010.11:49459182:C:T
NM_000124.4(ERCC6):c.4211G>A (p.Arg1404His)	ERCC6	R1404H	Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300038	10	50667132	10	49459086	300038	315536	rs755854972	NC_000010.11:49459085:C:T
NM_000124.4(ERCC6):c.4223A>C (p.Glu1408Ala)	ERCC6	E1408A	Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|not specified|not provided|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Feb 9, 2021)	criteria provided, conflicting interpretations	VCV000300037	10	50667120	10	49459074	300037	315528	rs61760167	NC_000010.11:49459073:T:G
NM_000124.4(ERCC6):c.4322C>T (p.Thr1441Ile)	ERCC6	T1441I	not provided|Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000300036	10	50667021	10	49458975	300036	321511	rs4253230	NC_000010.11:49458974:G:A
NM_000124.4(ERCC6):c.4391G>C (p.Cys1464Ser)	ERCC6	C1464S	Macular degeneration|COFS syndrome|Cockayne syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300035	10	50666952	10	49458906	300035	315526	rs759125039	NC_000010.11:49458905:C:G
NM_000124.4(ERCC6):c.4393G>A (p.Val1465Ile)	ERCC6	V1465I	not provided|Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000300034	10	50666950	10	49458904	300034	315513	rs201813523	NC_000010.11:49458903:C:T
NM_000124.4(ERCC6):c.*38A>G	ERCC6		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000300032	10	50666823	10	49458777	300032	315512	rs756639495	NC_000010.11:49458776:T:C
NM_000124.4(ERCC6):c.*53T>C	ERCC6		not provided|Macular degeneration|Cockayne syndrome|COFS syndrome	Benign(Last reviewed: Nov 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000300031	10	50666808	10	49458762	300031	321510	rs4253231	NC_000010.11:49458761:A:G
NM_000124.4(ERCC6):c.*118A>C	ERCC6		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Likely benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000300030	10	50666743	10	49458697	300030	310411	rs4253233	NC_000010.11:49458696:T:G
NM_000124.4(ERCC6):c.*341A>G	ERCC6		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300028	10	50666520	10	49458474	300028	310409	rs886047030	NC_000010.11:49458473:T:C
NM_000124.4(ERCC6):c.*379C>G	ERCC6		Macular degeneration|COFS syndrome|Cockayne syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300027	10	50666482	10	49458436	300027	310405	rs4253234	NC_000010.11:49458435:G:C
NM_000124.4(ERCC6):c.*388C>A	ERCC6		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300026	10	50666473	10	49458427	300026	322299	rs886047029	NC_000010.11:49458426:G:T
NM_000124.4(ERCC6):c.*482C>A	ERCC6		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300025	10	50666379	10	49458333	300025	322298	rs886047028	NC_000010.11:49458332:G:T
NM_000124.4(ERCC6):c.*643G>A	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000300024	10	50666218	10	49458172	300024	315497	rs886047027	NC_000010.11:49458171:C:T
NM_000124.4(ERCC6):c.*645G>C	ERCC6		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300023	10	50666216	10	49458170	300023	310398	rs886047026	NC_000010.11:49458169:C:G
NM_000124.4(ERCC6):c.*681G>A	ERCC6		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300022	10	50666180	10	49458134	300022	310393	rs547014227	NC_000010.11:49458133:C:T
NM_000124.4(ERCC6):c.*751G>A	ERCC6		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300021	10	50666110	10	49458064	300021	321509	rs886047025	NC_000010.11:49458063:C:T
NM_000124.4(ERCC6):c.*755A>G	ERCC6		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300020	10	50666106	10	49458060	300020	321508	rs886047024	NC_000010.11:49458059:T:C
NM_000124.4(ERCC6):c.*900C>T	ERCC6		Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000300019	10	50665961	10	49457915	300019	315492	rs189979670	NC_000010.11:49457914:G:A
NM_000124.4(ERCC6):c.*933G>A	ERCC6		not provided|Macular degeneration|Cockayne syndrome|COFS syndrome	Benign(Last reviewed: May 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000300018	10	50665928	10	49457882	300018	315490	rs3750751	NC_000010.11:49457881:C:T
NM_000124.4(ERCC6):c.*977A>G	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300017	10	50665884	10	49457838	300017	322297	rs765959190	NC_000010.11:49457837:T:C
NM_000124.4(ERCC6):c.*1112G>A	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300016	10	50665749	10	49457703	300016	321507	rs186262133	NC_000010.11:49457702:C:T
NM_000124.4(ERCC6):c.*1275C>G	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300015	10	50665586	10	49457540	300015	322296	rs182177140	NC_000010.11:49457539:G:C
NM_000124.4(ERCC6):c.*1279T>A	ERCC6		Macular degeneration|COFS syndrome|Cockayne syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300014	10	50665582	10	49457536	300014	322288	rs189942338	NC_000010.11:49457535:A:T
NM_000124.4(ERCC6):c.*1314G>A	ERCC6		Macular degeneration|COFS syndrome|Cockayne syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300013	10	50665547	10	49457501	300013	310392	rs542053472	NC_000010.11:49457500:C:T
NM_000124.4(ERCC6):c.*1327G>A	ERCC6		Macular degeneration|COFS syndrome|Cockayne syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300012	10	50665534	10	49457488	300012	310391	rs117289374	NC_000010.11:49457487:C:T
NM_000124.4(ERCC6):c.*1383T>G	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300011	10	50665478	10	49457432	300011	315487	rs886047023	NC_000010.11:49457431:A:C
NM_000124.4(ERCC6):c.*1780T>C	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300010	10	50665081	10	49457035	300010	321506	rs188228522	NC_000010.11:49457034:A:G
NM_000124.4(ERCC6):c.*1830T>C	ERCC6		Cockayne syndrome|Macular degeneration|COFS syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300009	10	50665031	10	49456985	300009	322279	rs11101137	NC_000010.11:49456984:A:G
NM_000124.4(ERCC6):c.*1860A>G	ERCC6		Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000300008	10	50665001	10	49456955	300008	315486	rs886047022	NC_000010.11:49456954:T:C
NM_000124.4(ERCC6):c.*1872C>T	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300007	10	50664989	10	49456943	300007	321495	rs115281814	NC_000010.11:49456942:G:A
NM_000124.4(ERCC6):c.*1933A>G	ERCC6		Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300006	10	50664928	10	49456882	300006	321494	rs748783305	NC_000010.11:49456881:T:C
NM_000124.4(ERCC6):c.*2137A>G	ERCC6		Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300003	10	50664724	10	49456678	300003	321490	rs114723899	NC_000010.11:49456677:T:C
NM_000124.4(ERCC6):c.*2155T>C	ERCC6		Macular degeneration|Cockayne syndrome|COFS syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300002	10	50664706	10	49456660	300002	322273	rs114183603	NC_000010.11:49456659:A:G
NM_000124.4(ERCC6):c.*2237C>T	ERCC6		Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000300001	10	50664624	10	49456578	300001	321486	rs192242583	NC_000010.11:49456577:G:A
NM_000124.4(ERCC6):c.*2337A>C	ERCC6		Macular degeneration|COFS syndrome|Cockayne syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300000	10	50664524	10	49456478	300000	310384	rs557944846	NC_000010.11:49456477:T:G
NM_000124.4(ERCC6):c.3650T>G (p.Phe1217Cys)	ERCC6	F1217C	Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 24, 2021)	criteria provided, conflicting interpretations	VCV000288967	10	50678356	10	49470310	288967	273204	rs61760166	NC_000010.11:49470309:A:C
NM_000124.4(ERCC6):c.2096C>T (p.Thr699Met)	ERCC6	T699M	COFS syndrome|Cockayne syndrome|Macular degeneration|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000287219	10	50690806	10	49482760	287219	271456	rs55698015	NC_000010.11:49482759:G:A
NM_000124.4(ERCC6):c.3634T>A (p.Cys1212Ser)	ERCC6	C1212S	Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|not provided	Uncertain significance(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000283555	10	50678372	10	49470326	283555	267792	rs886042655	NC_000010.11:49470325:A:T
NM_000124.4(ERCC6):c.2825C>T (p.Thr942Met)	ERCC6	T942M	Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B|not specified|not provided	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000255165	10	50680959	10	49472913	255165	253771	rs2228525	NC_000010.11:49472912:G:A
NM_000124.4(ERCC6):c.1992+32A>G	ERCC6		Cerebrooculofacioskeletal syndrome 1|UV-sensitive syndrome 1|not specified|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000255163	10	50691360	10	49483314	255163	253773	rs4253162	NC_000010.11:49483313:T:C
NM_000124.4(ERCC6):c.400C>T (p.Arg134Trp)	ERCC6|ERCC6-PGBD3	R134W	not specified|COFS syndrome|Macular degeneration|Cockayne syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2020)	criteria provided, conflicting interpretations	VCV000252466	10	50740611	10	49532565	252466	247041	rs148095899	NC_000010.11:49532564:G:A
NM_000124.4(ERCC6):c.1337G>A (p.Gly446Asp)	ERCC6|ERCC6-PGBD3|PGBD3	G446D	not provided|COFS syndrome|Cockayne syndrome|not specified|Macular degeneration	Benign/Likely benign(Last reviewed: May 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000235642	10	50732139	10	49524093	235642	237323	rs4253047	NC_000010.11:49524092:C:T
NM_000124.4(ERCC6):c.466C>T (p.Gln156Ter)	ERCC6|ERCC6-PGBD3	Q156*	Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|not provided	Pathogenic(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212733	10	50738843	10	49530797	212733	209352	rs751838040	NC_000010.11:49530796:G:A
NM_000124.4(ERCC6):c.2551T>C (p.Trp851Arg)	ERCC6	W851R	Cockayne syndrome B|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000210955	10	50682120	10	49474074	210955	207742	rs368728467	NC_000010.11:49474073:A:G
NM_000124.4(ERCC6):c.528A>G (p.Arg176=)	ERCC6|ERCC6-PGBD3		COFS syndrome|Cockayne syndrome|not specified|not provided|Macular degeneration	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000196213	10	50738781	10	49530735	196213	193374	rs4253027	NC_000010.11:49530734:T:C
NM_000124.4(ERCC6):c.4066G>A (p.Gly1356Ser)	ERCC6	G1356S	not provided|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Lung carcinoma|DE SANCTIS-CACCHIONE SYNDROME|Age-related macular degeneration 5|UV-sensitive syndrome 1|Premature ovarian failure 11	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000195555	10	50667277	10	49459231	195555	192716	rs574272317	NC_000010.11:49459230:C:T
NM_000124.4(ERCC6):c.3010C>T (p.Leu1004=)	ERCC6		not provided|Age-related macular degeneration 5|not specified|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000194696	10	50679081	10	49471035	194696	191859	rs2274097	NC_000010.11:49471034:G:A
NM_000124.4(ERCC6):c.3061A>G (p.Ile1021Val)	ERCC6	I1021V	not provided|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Mar 19, 2021)	criteria provided, conflicting interpretations	VCV000194695	10	50679030	10	49470984	194695	191858	rs41562713	NC_000010.11:49470983:T:C
NM_000124.4(ERCC6):c.2924G>A (p.Arg975Gln)	ERCC6	R975Q	not provided|COFS syndrome|Cockayne syndrome|Macular degeneration	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)	criteria provided, conflicting interpretations	VCV000194590	10	50680422	10	49472376	194590	191753	rs145720191	NC_000010.11:49472375:C:T
NM_000124.4(ERCC6):c.2403C>T (p.Ala801=)	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|not specified|not provided	Benign/Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000194152	10	50682268	10	49474222	194152	191315	rs114896216	NC_000010.11:49474221:G:A
NM_000124.4(ERCC6):c.2048G>A (p.Arg683Gln)	ERCC6	R683Q	Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|not provided	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000193557	10	50690854	10	49482808	193557	190720	rs148845653	NC_000010.11:49482807:C:T
NM_000124.4(ERCC6):c.670C>T (p.Leu224Phe)	ERCC6|ERCC6-PGBD3	L224F	Cockayne syndrome B|not provided|Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000190174	10	50732806	10	49524760	190174	188012	rs150935953	NC_000010.11:49524759:G:A
NM_000124.4(ERCC6):c.4186A>G (p.Arg1396Gly)	ERCC6	R1396G	DE SANCTIS-CACCHIONE SYNDROME|Premature ovarian failure 11|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5|Lung carcinoma|UV-sensitive syndrome 1|not specified|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000190173	10	50667157	10	49459111	190173	187986	rs745352643	NC_000010.11:49459110:T:C
NM_000124.4(ERCC6):c.3904C>T (p.Gln1302Ter)	ERCC6	Q1302*	Cockayne syndrome B	Pathogenic(Last reviewed: Jul 29, 2014)	criteria provided, single submitter	VCV000190170	10	50669477	10	49461431	190170	187989	rs786205174	NC_000010.11:49461430:G:A
NM_000124.4(ERCC6):c.3177T>C (p.Ser1059=)	ERCC6		Cockayne syndrome B|not specified|not provided|Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1	Benign/Likely benign(Last reviewed: Jan 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000190165	10	50678829	10	49470783	190165	187994	rs4253207	NC_000010.11:49470782:A:G
NM_000124.4(ERCC6):c.3122A>C (p.Gln1041Pro)	ERCC6	Q1041P	COFS syndrome|Cockayne syndrome|not provided|Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Lung carcinoma|Cockayne syndrome B|UV-sensitive syndrome 1|Age-related macular degeneration 5|Premature ovarian failure 11|Macular degeneration|DE SANCTIS-CACCHIONE SYNDROME|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 14, 2020)	criteria provided, conflicting interpretations	VCV000190164	10	50678884	10	49470838	190164	187995	rs139007661	NC_000010.11:49470837:T:G
NM_000124.4(ERCC6):c.2830-2A>G	ERCC6		Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Lung carcinoma|Cockayne syndrome B|UV-sensitive syndrome 1|Age-related macular degeneration 5|Premature ovarian failure 11|DE SANCTIS-CACCHIONE SYNDROME|Cockayne syndrome B|not provided	Pathogenic(Last reviewed: Nov 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000190163	10	50680518	10	49472472	190163	187996	rs373227647	NC_000010.11:49472471:T:C
NM_000124.4(ERCC6):c.2599-26A>G	ERCC6		Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cockayne syndrome B|Cockayne syndrome B|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 25, 2020)	criteria provided, conflicting interpretations	VCV000190162	10	50681659	10	49473613	190162	187997	rs4253196	NC_000010.11:49473612:T:C
NM_000124.4(ERCC6):c.2167C>T (p.Gln723Ter)	ERCC6	Q723*	Cockayne syndrome B|ERCC6-Related Disorders|DE SANCTIS-CACCHIONE SYNDROME|not provided	Pathogenic(Last reviewed: Sep 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000190160	10	50690735	10	49482689	190160	187999	rs151242354	NC_000010.11:49482688:G:A
NM_000124.4(ERCC6):c.2008C>T (p.Arg670Trp)	ERCC6	R670W	Cockayne syndrome B|Inborn genetic diseases	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000190158	10	50690894	10	49482848	190158	188001	rs202080674	NC_000010.11:49482847:G:A
NM_000124.4(ERCC6):c.1996C>T (p.Arg666Cys)	ERCC6	R666C	not specified|not provided|COFS syndrome|Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Lung carcinoma|Cockayne syndrome B|UV-sensitive syndrome 1|Age-related macular degeneration 5|Premature ovarian failure 11|Cockayne syndrome|Macular degeneration	Conflicting interpretations of pathogenicity(Last reviewed: Dec 28, 2020)	criteria provided, conflicting interpretations	VCV000190156	10	50690906	10	49482860	190156	188003	rs61760163	NC_000010.11:49482859:G:A
NM_000124.4(ERCC6):c.1954C>T (p.Arg652Ter)	ERCC6	R652*	Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cockayne syndrome B|Cockayne syndrome B|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000190155	10	50691430	10	49483384	190155	188004	rs767247987	NC_000010.11:49483383:G:A
NM_000124.4(ERCC6):c.1835G>A (p.Arg612Gln)	ERCC6	R612Q	not specified|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000190154	10	50691549	10	49483503	190154	188006	rs201894064	NC_000010.11:49483502:C:T
NM_000124.4(ERCC6):c.1821+7C>T	ERCC6		not provided|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|UV-sensitive syndrome 1|Macular degeneration|not specified|COFS syndrome|Cockayne syndrome	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000190153	10	50701156	10	49493110	190153	188007	rs4253132	NC_000010.11:49493109:G:A
NM_000124.4(ERCC6):c.1659G>T (p.Lys553Asn)	ERCC6	K553N	Age-related macular degeneration 5|DE SANCTIS-CACCHIONE SYNDROME|Premature ovarian failure 11|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5|Lung carcinoma|UV-sensitive syndrome 1|Cerebrooculofacioskeletal syndrome 1|not specified|not provided|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000190151	10	50708610	10	49500564	190151	188008	rs116373975	NC_000010.11:49500563:C:A
NM_000124.4(ERCC6):c.150G>A (p.Val50=)	ERCC6|ERCC6-PGBD3		not specified|not provided|Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Aug 31, 2021)	criteria provided, conflicting interpretations	VCV000190149	10	50740861	10	49532815	190149	188013	rs80133923	NC_000010.11:49532814:C:T
NM_000124.4(ERCC6):c.1526+1G>T	ERCC6		DE SANCTIS-CACCHIONE SYNDROME|Cockayne syndrome|Cockayne syndrome B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000190147	10	50713929	10	49505883	190147	188009	rs371739894	NC_000010.11:49505882:C:A
NM_000124.4(ERCC6):c.4238A>G (p.Gln1413Arg)	ERCC6	Q1413R	Macular degeneration|COFS syndrome|not provided|Cockayne syndrome|not specified	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000129020	10	50667105	10	49459059	129020	134466	rs2228529	NC_000010.11:49459058:T:C
NM_000124.4(ERCC6):c.411G>A (p.Leu137=)	ERCC6|ERCC6-PGBD3		Cerebrooculofacioskeletal syndrome 1|UV-sensitive syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|not specified|Cockayne syndrome|Cockayne syndrome B|COFS syndrome|Macular degeneration|not provided	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000129019	10	50740600	10	49532554	129019	134465	rs4253013	NC_000010.11:49532553:C:T
NM_000124.4(ERCC6):c.3689G>C (p.Arg1230Pro)	ERCC6	R1230P	not specified|Macular degeneration|COFS syndrome|Cockayne syndrome|not provided	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000129018	10	50678317	10	49470271	129018	134464	rs4253211	NC_000010.11:49470270:C:G
NM_000124.4(ERCC6):c.3637A>G (p.Arg1213Gly)	ERCC6	R1213G	not provided|Macular degeneration|COFS syndrome|not specified|Cockayne syndrome	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000129017	10	50678369	10	49470323	129017	134463	rs2228527	NC_000010.11:49470322:T:C
NM_000124.4(ERCC6):c.3289A>G (p.Met1097Val)	ERCC6	M1097V	not specified|Macular degeneration|COFS syndrome|not provided|Cockayne syndrome	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000129016	10	50678717	10	49470671	129016	134462	rs2228526	NC_000010.11:49470670:T:C
NM_000124.4(ERCC6):c.2751C>T (p.Gly917=)	ERCC6		Cerebrooculofacioskeletal syndrome 1|UV-sensitive syndrome 1|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cockayne syndrome|Macular degeneration|not provided|COFS syndrome|not specified	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000129015	10	50681033	10	49472987	129015	134461	rs2229760	NC_000010.11:49472986:G:A
NM_000124.4(ERCC6):c.135C>G (p.Leu45=)	ERCC6|ERCC6-PGBD3		UV-sensitive syndrome 1|Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cockayne syndrome|Cockayne syndrome B|not provided|COFS syndrome|Macular degeneration|not specified	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000129014	10	50740876	10	49532830	129014	134460	rs2228524	NC_000010.11:49532829:G:C
NM_000124.4(ERCC6):c.1196G>A (p.Gly399Asp)	ERCC6|ERCC6-PGBD3|PGBD3	G399D	UV-sensitive syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome|Cockayne syndrome B|COFS syndrome|not provided|Macular degeneration|not specified	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000129013	10	50732280	10	49524234	129013	134459	rs2228528	NC_000010.11:49524233:C:T
NM_000124.4(ERCC6):c.3862C>T (p.Arg1288Ter)	ERCC6	R1288*	Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Inborn genetic diseases|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|not provided	Pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000031578	10	50669519	10	49461473	31578	40257	rs185142838	NC_000010.11:49461472:G:A
NM_000124.4(ERCC6):c.2047C>T (p.Arg683Ter)	ERCC6	R683*	not provided|ERCC6-Related Disorders|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001711	10	50690855	10	49482809	1711	16750	rs121917904	NC_000010.11:49482808:G:A
NM_000124.4(ERCC6):c.229C>T (p.Arg77Ter)	ERCC6|ERCC6-PGBD3	R77*	UV-sensitive syndrome 1|Cockayne syndrome B	Pathogenic(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	VCV000001708	10	50740782	10	49532736	1708	16747	rs121917903	NC_000010.11:49532735:G:A
NM_000124.4(ERCC6):c.3284C>G (p.Pro1095Arg)	ERCC6	P1095R	not provided|Age-related macular degeneration 5|DE SANCTIS-CACCHIONE SYNDROME|Cockayne syndrome B|not specified|Cerebrooculofacioskeletal syndrome 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 21, 2021)	criteria provided, conflicting interpretations	VCV000001707	10	50678722	10	49470676	1707	16746	rs4253208	NC_000010.11:49470675:G:C
NM_000124.4(ERCC6):c.1357C>T (p.Arg453Ter)	ERCC6|ERCC6-PGBD3|PGBD3	R453*	not provided|Cockayne syndrome B|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Premature ovarian failure 11|UV-sensitive syndrome 1|Lung carcinoma|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1	Pathogenic(Last reviewed: Feb 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001703	10	50732119	10	49524073	1703	16742	rs121917902	NC_000010.11:49524072:G:A
NM_000124.4(ERCC6):c.2203C>T (p.Arg735Ter)	ERCC6	R735*	none provided|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|ERCC6-Related Disorders|Lung carcinoma|Age-related macular degeneration 5|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Premature ovarian failure 11|UV-sensitive syndrome 1|Cerebrooculofacioskeletal syndrome 1|not provided	Pathogenic(Last reviewed: Apr 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001701	10	50686483	10	49478437	1701	16740	rs121917901	NC_000010.11:49478436:G:A
NM_000124.4(ERCC6):c.1550G>A (p.Trp517Ter)	ERCC6	W517*	Cockayne syndrome B	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000001700	10	50708719	10	49500673	1700	16739	rs121917900	NC_000010.11:49500672:C:T
NM_000124.4(ERCC6):c.958G>C (p.Val320Leu)	ERCC6-PGBD3|ERCC6	V320L	Age-related macular degeneration 5|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000879772	10	50732518	10	49524472	879772	865950		NC_000010.11:49524471:C:G
NM_000124.4(ERCC6):c.1237C>T (p.Arg413Trp)	ERCC6-PGBD3|ERCC6|PGBD3	R413W	Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000879712	10	50732239	10	49524193	879712	865949		NC_000010.11:49524192:G:A
NM_000124.4(ERCC6):c.423-9A>C	ERCC6-PGBD3|ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|not provided|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2020)	criteria provided, conflicting interpretations	VCV000879449	10	50738895	10	49530849	879449	868477		NC_000010.11:49530848:T:G
NM_000124.4(ERCC6):c.423-7T>C	ERCC6-PGBD3|ERCC6		Cerebrooculofacioskeletal syndrome 1|not provided|Cockayne syndrome B|Age-related macular degeneration 5	Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2020)	criteria provided, conflicting interpretations	VCV000879448	10	50738893	10	49530847	879448	868476		NC_000010.11:49530846:A:G
NM_000124.4(ERCC6):c.61C>T (p.Gln21Ter)	ERCC6-PGBD3|ERCC6	Q21*	Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551535	10	50740950	10	49532904	551535	545723	rs577021605	NC_000010.11:49532903:G:A
NM_000124.4(ERCC6):c.1397+1G>C	ERCC6-PGBD3|ERCC6|PGBD3		Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Inborn genetic diseases	Likely pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550708	10	50732078	10	49524032	550708	545698	rs1554793174	NC_000010.11:49524031:C:G
NM_000124.4(ERCC6):c.384C>T (p.Asp128=)	ERCC6-PGBD3|ERCC6		not provided|Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Nov 23, 2020)	criteria provided, conflicting interpretations	VCV000300094	10	50740627	10	49532581	300094	310458	rs146165518	NC_000010.11:49532580:G:A
NM_000124.4(ERCC6):c.643G>T (p.Glu215Ter)	ERCC6-PGBD3|ERCC6	E215*	not provided|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Premature ovarian failure 11	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000225905	10	50736472	10	49528426	225905	227716	rs875989810	NC_000010.11:49528425:C:A
NM_000124.4(ERCC6):c.1281C>T (p.Phe427=)	ERCC6-PGBD3|PGBD3|ERCC6		Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME	Likely benign(Last reviewed: Apr 6, 2017)	criteria provided, single submitter	VCV000077973	10	50732195	10	49524149	77973	88864	rs267602508	NC_000010.11:49524148:G:A
NM_000082.4(ERCC8):c.1041+1G>T	ERCC8		not provided	Pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV001075397	5	60186715	5	60890888	1075397	1060423		NC_000005.10:60890887:C:A
NM_000082.4(ERCC8):c.275+1G>T	ERCC8		not provided	Likely pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001066487	5	60217880	5	60922053	1066487	1055515		NC_000005.10:60922052:C:A
NM_000082.4(ERCC8):c.95T>A (p.Leu32Ter)	ERCC8	L32*	Cockayne syndrome type A	Likely pathogenic(Last reviewed: Dec 28, 2019)	no assertion criteria provided	VCV000984265	5	60224769	5	60928942	984265	971876		NC_000005.10:60928941:A:T
NM_000082.4(ERCC8):c.182C>G (p.Ser61Ter)	ERCC8	S3*, S61*	Cockayne syndrome type A	Likely pathogenic(Last reviewed: Mar 23, 2019)	no assertion criteria provided	VCV000984264	5	60217974	5	60922147	984264	971875		NC_000005.10:60922146:G:C
NM_000082.4(ERCC8):c.300C>A (p.Tyr100Ter)	ERCC8|ERCC8-AS1	Y100*, Y42*	Cockayne syndrome type A	Likely pathogenic(Last reviewed: May 19, 2019)	no assertion criteria provided	VCV000984263	5	60214191	5	60918364	984263	971874		NC_000005.10:60918363:G:T
NM_000082.4(ERCC8):c.397C>T (p.Gln133Ter)	ERCC8	Q133*, Q75*, T7I	Cockayne syndrome type A	Likely pathogenic(Last reviewed: Mar 11, 2020)	no assertion criteria provided	VCV000984262	5	60214094	5	60918267	984262	971873		NC_000005.10:60918266:G:A
NM_000082.4(ERCC8):c.642G>A (p.Trp214Ter)	ERCC8	W156*, W214*, W61*	Cockayne syndrome type A	Likely pathogenic(Last reviewed: Dec 25, 2019)	no assertion criteria provided	VCV000984261	5	60195530	5	60899703	984261	971872		NC_000005.10:60899702:C:T
NM_000082.4(ERCC8):c.903T>A (p.Cys301Ter)	ERCC8	C148*, C243*, C301*	Cockayne syndrome type A	Likely pathogenic(Last reviewed: Jan 31, 2020)	no assertion criteria provided	VCV000984143	5	60186854	5	60891027	984143	971871		NC_000005.10:60891026:A:T
NM_000082.4(ERCC8):c.976C>T (p.Gln326Ter)	ERCC8	Q173*, Q268*, Q326*	Cockayne syndrome type A	Likely pathogenic(Last reviewed: Feb 3, 2020)	no assertion criteria provided	VCV000984142	5	60186781	5	60890954	984142	971870		NC_000005.10:60890953:G:A
NM_000082.4(ERCC8):c.202A>T (p.Ile68Phe)	ERCC8	I10F, I68F	Cockayne syndrome type A	Pathogenic	no assertion criteria provided	VCV000974940	5	60217954	5	60922127	974940	963236		NC_000005.10:60922126:T:A
NM_000082.4(ERCC8):c.797A>C (p.Asp266Ala)	ERCC8	D113A, D208A, D266A	Cockayne syndrome type A	Likely pathogenic	criteria provided, single submitter	VCV000973767	5	60194149	5	60898322	973767	962059		NC_000005.10:60898321:T:G
NM_000082.4(ERCC8):c.-33C>T	ERCC8		Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907761	5	60240868	5	60945041	907761	894594		NC_000005.10:60945040:G:A
NM_000082.4(ERCC8):c.1159G>C (p.Asp387His)	ERCC8	D329H, D387H, D234H	Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907715	5	60170474	5	60874647	907715	894585		NC_000005.10:60874646:C:G
NM_000082.4(ERCC8):c.*7T>A	ERCC8		Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907714	5	60170435	5	60874608	907714	894584		NC_000005.10:60874607:A:T
NM_000082.4(ERCC8):c.*113A>G	ERCC8		Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000907713	5	60170329	5	60874502	907713	894583		NC_000005.10:60874501:T:C
NM_000082.4(ERCC8):c.*116T>C	ERCC8		Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907712	5	60170326	5	60874499	907712	894582		NC_000005.10:60874498:A:G
NM_000082.4(ERCC8):c.302G>C (p.Ser101Thr)	ERCC8|ERCC8-AS1	S101T, S43T	Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906768	5	60214189	5	60918362	906768	894593		NC_000005.10:60918361:C:G
NM_000082.4(ERCC8):c.382G>A (p.Asp128Asn)	ERCC8	D70N, D128N, G2E	Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906767	5	60214109	5	60918282	906767	894592		NC_000005.10:60918281:C:T
NM_000082.4(ERCC8):c.399+3A>G	ERCC8		Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906766	5	60214089	5	60918262	906766	896122		NC_000005.10:60918261:T:C
NM_000082.4(ERCC8):c.419T>G (p.Phe140Cys)	ERCC8	F82C, F140C	Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906765	5	60200681	5	60904854	906765	894591		NC_000005.10:60904853:A:C
NM_000082.4(ERCC8):c.*377C>G	ERCC8		Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906687	5	60170065	5	60874238	906687	894581		NC_000005.10:60874237:G:C
NM_000082.4(ERCC8):c.*458T>C	ERCC8		Cockayne syndrome type A	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906686	5	60169984	5	60874157	906686	894580		NC_000005.10:60874156:A:G
NM_000082.4(ERCC8):c.*583T>C	ERCC8		Cockayne syndrome type A	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906685	5	60169859	5	60874032	906685	894579		NC_000005.10:60874031:A:G
NM_000082.4(ERCC8):c.*602C>G	ERCC8		Cockayne syndrome type A	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000906684	5	60169840	5	60874013	906684	894578		NC_000005.10:60874012:G:C
NM_000082.4(ERCC8):c.*644G>A	ERCC8		Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906683	5	60169798	5	60873971	906683	894577		NC_000005.10:60873970:C:T
NM_000082.4(ERCC8):c.485G>A (p.Gly162Asp)	ERCC8	G162D, G104D, G9D	Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000905171	5	60199540	5	60903713	905171	894590		NC_000005.10:60903712:C:T
NM_000082.4(ERCC8):c.590G>A (p.Arg197His)	ERCC8	R44H, R197H, R139H	Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905170	5	60198296	5	60902469	905170	894589		NC_000005.10:60902468:C:T
NM_000082.4(ERCC8):c.872G>A (p.Ser291Asn)	ERCC8	S138N, S233N, S291N	Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904373	5	60186885	5	60891058	904373	894588		NC_000005.10:60891057:C:T
NM_000082.4(ERCC8):c.911G>A (p.Ser304Asn)	ERCC8	S151N, S246N, S304N	Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904372	5	60186846	5	60891019	904372	894587		NC_000005.10:60891018:C:T
NM_000082.4(ERCC8):c.945C>T (p.Thr315=)	ERCC8		Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904371	5	60186812	5	60890985	904371	894586		NC_000005.10:60890984:G:A
NM_000082.4(ERCC8):c.185G>A (p.Gly62Asp)	ERCC8	G62D, G4D	Cockayne syndrome type A	Uncertain significance	no assertion criteria provided	VCV000870559	5	60217971	5	60922144	870559	858721		NC_000005.10:60922143:C:T
NM_000082.4(ERCC8):c.802C>T (p.Arg268Ter)	ERCC8	R115*, R210*, R268*	Cockayne syndrome type A|not provided	Pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, single submitter	VCV000838966	5	60194144	5	60898317	838966	830906		NC_000005.10:60898316:G:A
NM_000082.4(ERCC8):c.481+1G>C	ERCC8		Cockayne syndrome type A	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000807412	5	60200618	5	60904791	807412	798562	rs1580007152	NC_000005.10:60904790:C:G
NM_000082.4(ERCC8):c.1023A>G (p.Val341=)	ERCC8		not provided|Cockayne syndrome type A	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000765809	5	60186734	5	60890907	765809	765160	rs138173863	NC_000005.10:60890906:T:C
NM_000082.4(ERCC8):c.655G>C (p.Ala219Pro)	ERCC8	A161P, A66P, A219P	Cockayne syndrome type A|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)	criteria provided, conflicting interpretations	VCV000702384	5	60195517	5	60899690	702384	691875	rs150727525	NC_000005.10:60899689:C:G
NM_000082.4(ERCC8):c.504A>G (p.Val168=)	ERCC8		not provided|Cockayne syndrome type A	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000701917	5	60199521	5	60903694	701917	686762	rs35366433	NC_000005.10:60903693:T:C
NM_000082.4(ERCC8):c.481G>A (p.Val161Ile)	ERCC8	V103I, V161I	Cockayne syndrome type A|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2021)	criteria provided, conflicting interpretations	VCV000645783	5	60200619	5	60904792	645783	633993	rs148393161	NC_000005.10:60904791:C:T
NM_000082.4(ERCC8):c.769G>A (p.Gly257Arg)	ERCC8	G257R, G104R, G199R	Cockayne syndrome type A	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000590788	5	60194177	5	60898350	590788	581726	rs770499406	NC_000005.10:60898349:C:T
NM_000082.4(ERCC8):c.78-2A>T	ERCC8		Cockayne syndrome type A	Pathogenic(Last reviewed: Sep 1, 2018)	no assertion criteria provided	VCV000586967	5	60224788	5	60928961	586967	578013	rs748379243	NC_000005.10:60928960:T:A
NM_000082.4(ERCC8):c.551-1G>A	ERCC8		Cockayne syndrome type A	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000558564	5	60198336	5	60902509	558564	543875	rs1554073316	NC_000005.10:60902508:C:T
NM_000082.4(ERCC8):c.1122+1G>A	ERCC8		Cockayne syndrome type A	Likely pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000558388	5	60183266	5	60887439	558388	543431	rs1482664387	NC_000005.10:60887438:C:T
NM_000082.4(ERCC8):c.843+1G>T	ERCC8		Cockayne syndrome type A	Likely pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000558214	5	60194102	5	60898275	558214	543433	rs1305258765	NC_000005.10:60898274:C:A
NM_174889.5(NDUFAF2):c.13C>T (p.Gln5Ter)	ERCC8|NDUFAF2	Q5*	Cockayne syndrome type A	Uncertain significance(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000558212	5	60241095	5	60945268	558212	543789	rs772489808	NC_000005.10:60945267:C:T
NM_174889.5(NDUFAF2):c.109C>T (p.Gln37Ter)	ERCC8|NDUFAF2	Q37*	Cockayne syndrome type A	Uncertain significance(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000557964	5	60241191	5	60945364	557964	543449	rs1554076325	NC_000005.10:60945363:C:T
NM_000082.4(ERCC8):c.1042-1G>A	ERCC8		Cockayne syndrome type A	Likely pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000557955	5	60183348	5	60887521	557955	543778	rs897535441	NC_000005.10:60887520:C:T
NM_000082.4(ERCC8):c.173+1G>A	ERCC8		not provided|Cockayne syndrome type A	Likely pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000554440	5	60224690	5	60928863	554440	543788	rs1476095782	NC_000005.10:60928862:C:T
NM_000082.4(ERCC8):c.276-2A>G	ERCC8|ERCC8-AS1		Cockayne syndrome type A	Likely pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000554190	5	60214217	5	60918390	554190	543786	rs1554074597	NC_000005.10:60918389:T:C
NM_000082.4(ERCC8):c.77+2T>G	ERCC8		Cockayne syndrome type A	Likely pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000553277	5	60240757	5	60944930	553277	543704	rs1554076239	NC_000005.10:60944929:A:C
NM_000082.4(ERCC8):c.482-2A>G	ERCC8		Cockayne syndrome type A	Likely pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000553264	5	60199545	5	60903718	553264	543782	rs1554073420	NC_000005.10:60903717:T:C
NM_000082.4(ERCC8):c.719-2A>G	ERCC8		Cockayne syndrome type A	Likely pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	VCV000552365	5	60194229	5	60898402	552365	543780	rs1554073117	NC_000005.10:60898401:T:C
NM_000082.4(ERCC8):c.1042-2A>G	ERCC8		Cockayne syndrome type A|UV-sensitive syndrome 2|Cockayne syndrome type A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551594	5	60183349	5	60887522	551594	543869	rs372237310	NC_000005.10:60887521:T:C
NM_000082.4(ERCC8):c.1042-1G>C	ERCC8		Cockayne syndrome type A	Likely pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, single submitter	VCV000551549	5	60183348	5	60887521	551549	543775	rs897535441	NC_000005.10:60887520:C:G
NM_000082.4(ERCC8):c.618-1G>A	ERCC8		Cockayne syndrome type A|not provided	Pathogenic(Last reviewed: Aug 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551068	5	60195555	5	60899728	551068	543438	rs201464610	NC_000005.10:60899727:C:T
NM_000082.4(ERCC8):c.719-2A>T	ERCC8		Cockayne syndrome type A	Likely pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000550365	5	60194229	5	60898402	550365	543435	rs1554073117	NC_000005.10:60898401:T:A
NM_000082.4(ERCC8):c.399+1G>A	ERCC8		not provided|Cockayne syndrome type A	Likely pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000550005	5	60214091	5	60918264	550005	543702	rs774047625	NC_000005.10:60918263:C:T
NM_000082.4(ERCC8):c.1012G>A (p.Asp338Asn)	ERCC8	D338N, D185N, D280N	Cockayne syndrome type A|UV-sensitive syndrome 2|Cockayne syndrome type A|not provided	Uncertain significance(Last reviewed: Feb 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000546240	5	60186745	5	60890918	546240	536698	rs141845482	NC_000005.10:60890917:C:T
NM_000082.4(ERCC8):c.580T>C (p.Trp194Arg)	ERCC8	W194R, W136R, W41R	not provided	Likely pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000450829	5	60198306	5	60902479	450829	443809	rs1554073311	NC_000005.10:60902478:A:G
NM_000082.4(ERCC8):c.173+1158A>G	ERCC8		Cockayne syndrome type A	Benign(Last reviewed: Jun 15, 2017)	no assertion criteria provided	VCV000430631	5	60223533	5	60927706	430631	423862	rs4647068	NC_000005.10:60927705:T:C
NM_174889.5(NDUFAF2):c.114C>G (p.Tyr38Ter)	ERCC8|NDUFAF2	Y38*	not specified|not provided|Mitochondrial complex 1 deficiency, nuclear type 10|Mitochondrial complex I deficiency, nuclear type 1|Cockayne syndrome type A	Conflicting interpretations of pathogenicity(Last reviewed: Aug 28, 2021)	criteria provided, conflicting interpretations	VCV000419231	5	60241196	5	60945369	419231	406756	rs199754807	NC_000005.10:60945368:C:G
NM_000082.4(ERCC8):c.173+1119G>C	ERCC8		Cockayne syndrome type A	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000397640	5	60223572	5	60927745	397640	384613	rs1043679457	NC_000005.10:60927744:C:G
NM_000082.3(ERCC8):c.-133C>G	ERCC8|NDUFAF2		Cockayne syndrome|not provided	Likely benign(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000369503	5	60240968	5	60945141	369503	353732	rs4647037	NC_000005.10:60945140:G:C
NM_174889.5(NDUFAF2):c.18T>G (p.Asp6Glu)	ERCC8|NDUFAF2	D6E	Cockayne syndrome type A|Mitochondrial complex I deficiency|Leigh syndrome	Uncertain significance(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000354032	5	60241100	5	60945273	354032	304368	rs886060726	NC_000005.10:60945272:T:G
NM_174889.4(NDUFAF2):c.-91C>T	ERCC8|NDUFAF2		Leigh syndrome|Cockayne syndrome|not provided|Mitochondrial complex I deficiency	Benign/Likely benign(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000354028	5	60240992	5	60945165	354028	304363	rs4647036	NC_000005.10:60945164:C:T
NM_174889.4(NDUFAF2):c.-97A>G	ERCC8|NDUFAF2		Leigh syndrome|Cockayne syndrome|not provided|Mitochondrial complex I deficiency	Benign(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000354027	5	60240986	5	60945159	354027	297944	rs158922	NC_000005.10:60945158:A:G
NM_000082.4(ERCC8):c.-25G>C	ERCC8		Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000354025	5	60240860	5	60945033	354025	300100	rs745927528	NC_000005.10:60945032:C:G
NM_000082.4(ERCC8):c.-23T>G	ERCC8		Cockayne syndrome type A|Cockayne syndrome|not provided	Benign/Likely benign(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000354024	5	60240858	5	60945031	354024	297932	rs4647038	NC_000005.10:60945030:A:C
NM_000082.4(ERCC8):c.66G>A (p.Glu22=)	ERCC8		not provided|Cockayne syndrome type A	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000354023	5	60240770	5	60944943	354023	297931	rs149130938	NC_000005.10:60944942:C:T
NM_000082.4(ERCC8):c.149A>G (p.Asp50Gly)	ERCC8	D50G	Cockayne syndrome type A|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000354022	5	60224715	5	60928888	354022	297930	rs373174008	NC_000005.10:60928887:T:C
NM_000082.4(ERCC8):c.173+9A>G	ERCC8		Cockayne syndrome type A|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 22, 2020)	criteria provided, conflicting interpretations	VCV000354021	5	60224682	5	60928855	354021	304360	rs143356896	NC_000005.10:60928854:T:C
NM_000082.4(ERCC8):c.311C>G (p.Thr104Ser)	ERCC8|ERCC8-AS1	T104S, T46S	Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000354020	5	60214180	5	60918353	354020	300099	rs886060722	NC_000005.10:60918352:G:C
NM_000082.4(ERCC8):c.409G>A (p.Val137Ile)	ERCC8	V137I, V79I	Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000354019	5	60200691	5	60904864	354019	297927	rs150952570	NC_000005.10:60904863:C:T
NM_000082.4(ERCC8):c.430G>A (p.Val144Ile)	ERCC8	V144I, V86I	Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000354018	5	60200670	5	60904843	354018	304692	rs192695896	NC_000005.10:60904842:C:T
NM_000082.4(ERCC8):c.472T>C (p.Leu158=)	ERCC8		not provided|Cockayne syndrome type A	Conflicting interpretations of pathogenicity(Last reviewed: Nov 26, 2020)	criteria provided, conflicting interpretations	VCV000354017	5	60200628	5	60904801	354017	304356	rs561001438	NC_000005.10:60904800:A:G
NM_000082.4(ERCC8):c.551-10G>T	ERCC8		not provided|Cockayne syndrome type A	Conflicting interpretations of pathogenicity(Last reviewed: Sep 7, 2020)	criteria provided, conflicting interpretations	VCV000354016	5	60198345	5	60902518	354016	304354	rs758296965	NC_000005.10:60902517:C:A
NM_000082.4(ERCC8):c.812T>C (p.Leu271Pro)	ERCC8	L271P, L118P, L213P	Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000354015	5	60194134	5	60898307	354015	304331	rs886060721	NC_000005.10:60898306:A:G
NM_000082.4(ERCC8):c.1070A>G (p.Asn357Ser)	ERCC8	N357S, N204S, N299S	Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000354014	5	60183319	5	60887492	354014	297923	rs199590588	NC_000005.10:60887491:T:C
NM_000082.4(ERCC8):c.1105G>C (p.Val369Leu)	ERCC8	V369L, V311L, V216L	not provided|Cockayne syndrome type A	Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000354013	5	60183284	5	60887457	354013	297922	rs543291626	NC_000005.10:60887456:C:G
NM_000082.4(ERCC8):c.*36C>T	ERCC8		Cockayne syndrome type A|not provided	Benign(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000354012	5	60170406	5	60874579	354012	300098	rs4647152	NC_000005.10:60874578:G:A
NM_000082.4(ERCC8):c.*105T>C	ERCC8		Cockayne syndrome type A|not provided	Benign(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000354011	5	60170337	5	60874510	354011	300097	rs3117	NC_000005.10:60874509:A:G
NM_000082.4(ERCC8):c.*237T>C	ERCC8		Cockayne syndrome type A|not provided	Benign/Likely benign(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000354010	5	60170205	5	60874378	354010	297919	rs4647153	NC_000005.10:60874377:A:G
NM_000082.4(ERCC8):c.*439G>T	ERCC8		Cockayne syndrome type A	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000354008	5	60170003	5	60874176	354008	300093	rs4647155	NC_000005.10:60874175:C:A
NM_000082.4(ERCC8):c.*462T>A	ERCC8		Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000354007	5	60169980	5	60874153	354007	297917	rs886060719	NC_000005.10:60874152:A:T
NM_000082.4(ERCC8):c.*519C>A	ERCC8		Cockayne syndrome type A	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000354006	5	60169923	5	60874096	354006	304328	rs4647157	NC_000005.10:60874095:G:T
NM_000082.4(ERCC8):c.*724C>G	ERCC8		Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000354005	5	60169718	5	60873891	354005	304691	rs886060718	NC_000005.10:60873890:G:C
NM_000082.4(ERCC8):c.*725T>G	ERCC8		Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000354004	5	60169717	5	60873890	354004	297911	rs549186090	NC_000005.10:60873889:A:C
NM_000082.4(ERCC8):c.*763A>C	ERCC8		Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000354003	5	60169679	5	60873852	354003	297902	rs886060717	NC_000005.10:60873851:T:G
NM_000082.4(ERCC8):c.250T>C (p.Cys84Arg)	ERCC8	C84R, C26R	not provided|Cockayne syndrome type A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000288320	5	60217906	5	60922079	288320	272557	rs146740678	NC_000005.10:60922078:A:G
NM_000082.4(ERCC8):c.839C>A (p.Thr280Lys)	ERCC8	T280K, T222K, T127K	not provided|Cockayne syndrome type A|Hereditary breast and ovarian cancer syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 7, 2021)	criteria provided, conflicting interpretations	VCV000198989	5	60194107	5	60898280	198989	196149	rs61754098	NC_000005.10:60898279:G:T
NM_000082.4(ERCC8):c.1080T>C (p.Ala360=)	ERCC8		not specified|Cockayne syndrome type A|not provided	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000193795	5	60183309	5	60887482	193795	190958	rs4647130	NC_000005.10:60887481:A:G
NM_000082.4(ERCC8):c.435T>C (p.Tyr145=)	ERCC8		not provided|Cockayne syndrome type A|not specified|UV-sensitive syndrome 2	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000190177	5	60200665	5	60904838	190177	187981	rs4647100	NC_000005.10:60904837:A:G
NM_000082.4(ERCC8):c.363T>C (p.Asp121=)	ERCC8|ERCC8-AS1		not specified|not provided|Cockayne syndrome type A	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000190176	5	60214128	5	60918301	190176	187982	rs4647088	NC_000005.10:60918300:A:G
NM_174889.5(NDUFAF2):c.60G>A (p.Lys20=)	ERCC8|NDUFAF2		not specified|Leigh syndrome|not provided|Mitochondrial complex I deficiency, nuclear type 1|Cockayne syndrome	Benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000129691	5	60241142	5	60945315	129691	135137	rs158921	NC_000005.10:60945314:G:A
NM_000082.4(ERCC8):c.478G>A (p.Ala160Thr)	ERCC8	A160T, A102T	Cockayne syndrome type A|not provided	Uncertain significance(Last reviewed: Dec 23, 2016)	criteria provided, single submitter	VCV000068753	5	60200622	5	60904795	68753	79645	rs281875222	NC_000005.10:60904794:C:T
NM_000082.4(ERCC8):c.613G>C (p.Ala205Pro)	ERCC8	A205P, A147P, A52P	not provided|Cockayne syndrome type A	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2021)	criteria provided, conflicting interpretations	VCV000001718	5	60198273	5	60902446	1718	16757	rs121434326	NC_000005.10:60902445:C:G
NM_000082.4(ERCC8):c.479C>T (p.Ala160Val)	ERCC8	A160V, A102V	not provided|Cockayne syndrome type A	Conflicting interpretations of pathogenicity(Last reviewed: Mar 26, 2021)	criteria provided, conflicting interpretations	VCV000001717	5	60200621	5	60904794	1717	16756	rs121434325	NC_000005.10:60904793:G:A
NM_000082.4(ERCC8):c.37G>T (p.Glu13Ter)	ERCC8|NDUFAF2	E13*	Cockayne syndrome|not provided|Cockayne syndrome type A	Pathogenic(Last reviewed: Dec 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001716	5	60240799	5	60944972	1716	16755	rs121434324	NC_000005.10:60944971:C:A
NM_000082.4(ERCC8):c.966C>A (p.Tyr322Ter)	ERCC8	Y322*, Y264*, Y169*	not provided|Cockayne syndrome type A	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV000001715	5	60186791	5	60890964	1715	16754	rs121434323	NC_000005.10:60890963:G:T
NM_000082.4(ERCC8):c.300C>G (p.Tyr100Ter)	ERCC8-AS1|ERCC8	Y100*, Y42*	Cockayne syndrome type A|not provided	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000371025	5	60214191	5	60918364	371025	357419	rs143367518	NC_000005.10:60918363:G:C
NM_000213.5(ITGB4):c.5054-25C>G	GALK1|ITGB4		not provided|Junctional epidermolysis bullosa, non-Herlitz type|Localized epidermolysis bullosa simplex|Epidermolysis bullosa junctionalis with pyloric atresia	Benign(Last reviewed: Aug 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV001240734	17	73752999	17	75756918	1240734	1231555		NC_000017.11:75756917:C:G
NM_000213.5(ITGB4):c.4067C>T (p.Ser1356Phe)	GALK1|ITGB4	S1356F	Localized epidermolysis bullosa simplex|Epidermolysis bullosa junctionalis with pyloric atresia	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000892370	17	73748617	17	75752536	892370	878471		NC_000017.11:75752535:C:T
NM_000213.5(ITGB4):c.5218+2T>C	GALK1|ITGB4		Epidermolysis bullosa junctionalis with pyloric atresia|Localized epidermolysis bullosa simplex|Junctional epidermolysis bullosa, non-Herlitz type|Deficiency of galactokinase	Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2021)	criteria provided, conflicting interpretations	VCV000552889	17	73753190	17	75757109	552889	548358	rs780675808	NC_000017.11:75757108:T:C
NM_000213.5(ITGB4):c.*25C>T	GALK1|ITGB4		not provided|Epidermolysis bullosa junctionalis with pyloric atresia|Localized epidermolysis bullosa simplex|Junctional epidermolysis bullosa, non-Herlitz type|Deficiency of galactokinase	Benign(Last reviewed: Aug 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000325219	17	73753661	17	75757580	325219	345931	rs9367	NC_000017.11:75757579:C:T
NM_000213.5(ITGB4):c.5336T>C (p.Leu1779Pro)	GALK1|ITGB4	L1779P, L1709P, L1762P	Localized epidermolysis bullosa simplex|Epidermolysis bullosa junctionalis with pyloric atresia|not provided|Deficiency of galactokinase|not specified|Junctional epidermolysis bullosa, non-Herlitz type	Benign(Last reviewed: Aug 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000255543	17	73753503	17	75757422	255543	256413	rs871443	NC_000017.11:75757421:T:C
NM_000213.5(ITGB4):c.4521C>G (p.Pro1507=)	GALK1|ITGB4		Localized epidermolysis bullosa simplex|Epidermolysis bullosa junctionalis with pyloric atresia|Deficiency of galactokinase|not specified|Junctional epidermolysis bullosa, non-Herlitz type|not provided	Benign(Last reviewed: Aug 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000255542	17	73750859	17	75754778	255542	256412	rs8669	NC_000017.11:75754777:C:G
NM_000213.5(ITGB4):c.5329+2T>C	GALK1|ITGB4		Localized epidermolysis bullosa simplex|Junctional epidermolysis bullosa, non-Herlitz type|Epidermolysis bullosa junctionalis with pyloric atresia	Likely pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000225396	17	73753393	17	75757312	225396	227396	rs762236241	NC_000017.11:75757311:T:C
NM_000213.5(ITGB4):c.3474+21T>C	ITGB4		Junctional epidermolysis bullosa, non-Herlitz type|Localized epidermolysis bullosa simplex|Epidermolysis bullosa junctionalis with pyloric atresia|not provided	Benign(Last reviewed: Aug 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV001250597	17	73746370	17	75750289	1250597	1239684		NC_000017.11:75750288:T:C
NM_000213.5(ITGB4):c.2524C>T (p.Gln842Ter)	ITGB4	Q842*	Localized epidermolysis bullosa simplex	Pathogenic	criteria provided, single submitter	VCV001077026	17	73736516	17	75740435	1077026	1065678		NC_000017.11:75740434:C:T
NM_000213.5(ITGB4):c.4014G>C (p.Gln1338His)	ITGB4|GALK1	Q1338H	Localized epidermolysis bullosa simplex	Uncertain significance(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000931093	17	73748564	17	75752483	931093	919771		NC_000017.11:75752482:G:C
NM_000213.5(ITGB4):c.2422G>A (p.Ala808Thr)	ITGB4	A808T	Epidermolysis bullosa junctionalis with pyloric atresia|not provided|Localized epidermolysis bullosa simplex	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2019)	criteria provided, conflicting interpretations	VCV000325162	17	73736128	17	75740047	325162	329900	rs147480547	NC_000017.11:75740046:G:A
NM_000526.5(KRT14):c.1264G>A (p.Glu422Lys)	KRT14	E422K	Localized epidermolysis bullosa simplex|not provided	Pathogenic(Last reviewed: Oct 28, 2021)	no assertion criteria provided	VCV000014623	17	39739497	17	41583245	14623	29662	rs58762773	NC_000017.11:41583244:C:T
NM_000526.5(KRT14):c.357G>A (p.Met119Ile)	KRT14	M119I	not provided|Localized epidermolysis bullosa simplex	Pathogenic(Last reviewed: Sep 1, 1997)	no assertion criteria provided	VCV000014620	17	39742730	17	41586478	14620	29659	rs57358989	NC_000017.11:41586477:C:T
NM_000424.4(KRT5):c.991C>T (p.Arg331Cys)	KRT5	R331C	not provided|Localized epidermolysis bullosa simplex	Pathogenic(Last reviewed: Apr 9, 2016)	criteria provided, single submitter	VCV000066298	12	52911475	12	52517691	66298	77195	rs61297109	NC_000012.12:52517690:G:A
NM_000424.4(KRT5):c.1636C>A (p.Leu546Ile)	KRT5	L546I	not provided|Localized epidermolysis bullosa simplex	Benign/Likely benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066226	12	52908863	12	52515079	66226	77123	rs114734812	NC_000012.12:52515078:G:T
NM_000424.4(KRT5):c.1411C>T (p.Arg471Cys)	KRT5	R471C	not provided|Epidermolysis bullosa simplex|Localized epidermolysis bullosa simplex|Epidermolysis bullosa simplex, Koebner type	Uncertain significance(Last reviewed: Feb 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000066213	12	52910449	12	52516665	66213	77110	rs267607448	NC_000012.12:52516664:G:A
NM_000424.4(KRT5):c.1429G>A (p.Glu477Lys)	KRT5	E477K	not provided|Epidermolysis bullosa simplex Dowling-Meara type|Localized epidermolysis bullosa simplex|Epidermolysis bullosa simplex with mottled pigmentation|Epidermolysis bullosa simplex	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021174	12	52910431	12	52516647	21174	34026	rs59190510	NC_000012.12:52516646:C:T
NM_000424.4(KRT5):c.980T>C (p.Met327Thr)	KRT5	M327T	Epidermolysis bullosa simplex 2C, localized|not provided|Dowling-Degos disease 1|Epidermolysis bullosa simplex, autosomal recessive|Epidermolysis bullosa simplex, Koebner type|Epidermolysis bullosa simplex with migratory circinate erythema|Epidermolysis bullosa simplex with mottled pigmentation|Epidermolysis bullosa simplex Dowling-Meara type|Localized epidermolysis bullosa simplex|Epidermolysis bullosa simplex, Koebner type	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014641	12	52911486	12	52517702	14641	29680	rs58072617	NC_000012.12:52517701:A:G
NM_000124.4(ERCC6):c.1379A>C (p.Tyr460Ser)	PGBD3|ERCC6-PGBD3|ERCC6	Y460S	Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000878760	10	50732097	10	49524051	878760	865948		NC_000010.11:49524050:T:G
NM_000124.4(ERCC6):c.1274A>C (p.Asp425Ala)	PGBD3|ERCC6|ERCC6-PGBD3	D425A	Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 1, 2021)	criteria provided, conflicting interpretations	VCV000300083	10	50732202	10	49524156	300083	322326	rs4253046	NC_000010.11:49524155:T:G
NM_201631.4(TGM5):c.509A>G (p.Gln170Arg)	TGM5	Q170R, Q88R	Peeling skin syndrome 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887704	15	43548812	15	43256614	887704	873550		NC_000015.10:43256613:T:C
NM_201631.4(TGM5):c.600G>C (p.Lys200Asn)	TGM5	K200N, K118N	Peeling skin syndrome 2	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000887703	15	43545788	15	43253590	887703	873549		NC_000015.10:43253589:C:G
NM_201631.4(TGM5):c.607C>T (p.His203Tyr)	TGM5	H203Y, H121Y	Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000887702	15	43545781	15	43253583	887702	873548		NC_000015.10:43253582:G:A
NM_201631.4(TGM5):c.1714+14C>T	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887645	15	43527653	15	43235455	887645	876512		NC_000015.10:43235454:G:A
NM_201631.4(TGM5):c.1716A>G (p.Ala572=)	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887644	15	43527126	15	43234928	887644	873540		NC_000015.10:43234927:T:C
NM_201631.4(TGM5):c.1750T>C (p.Tyr584His)	TGM5	Y584H, Y502H	Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887643	15	43527092	15	43234894	887643	873539		NC_000015.10:43234893:A:G
NM_201631.4(TGM5):c.1868C>T (p.Thr623Met)	TGM5	T541M, T623M	Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887642	15	43526974	15	43234776	887642	873538		NC_000015.10:43234775:G:A
NM_201631.4(TGM5):c.1891G>C (p.Val631Leu)	TGM5	V549L, V631L	Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887463	15	43525870	15	43233672	887463	873537		NC_000015.10:43233671:C:G
NM_201631.4(TGM5):c.1941G>A (p.Ser647=)	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887462	15	43525820	15	43233622	887462	873536		NC_000015.10:43233621:C:T
NM_201631.4(TGM5):c.1970T>C (p.Val657Ala)	TGM5	V575A, V657A	Peeling skin syndrome 2	Benign(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000887461	15	43525791	15	43233593	887461	873535		NC_000015.10:43233592:A:G
NM_201631.4(TGM5):c.*510A>G	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887460	15	43524879	15	43232681	887460	873534		NC_000015.10:43232680:T:C
NM_201631.4(TGM5):c.810C>T (p.Cys270=)	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000886455	15	43545009	15	43252811	886455	873547		NC_000015.10:43252810:G:A
NM_201631.4(TGM5):c.820C>A (p.Arg274Ser)	TGM5	R192S, R274S	Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000886454	15	43544999	15	43252801	886454	873546		NC_000015.10:43252800:G:T
NM_201631.4(TGM5):c.834C>T (p.Cys278=)	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886453	15	43544985	15	43252787	886453	873545		NC_000015.10:43252786:G:A
NM_201631.4(TGM5):c.850G>A (p.Val284Ile)	TGM5	V202I, V284I	Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000886452	15	43544969	15	43252771	886452	873544		NC_000015.10:43252770:C:T
NM_201631.4(TGM5):c.863-12C>T	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886451	15	43533200	15	43241002	886451	876514		NC_000015.10:43241001:G:A
NM_201631.4(TGM5):c.1080C>T (p.Asp360=)	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000885433	15	43531386	15	43239188	885433	873543		NC_000015.10:43239187:G:A
NM_201631.4(TGM5):c.1106-9C>G	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000885432	15	43531263	15	43239065	885432	876513		NC_000015.10:43239064:G:C
NM_201631.4(TGM5):c.258C>G (p.Ser86Arg)	TGM5	S86R	Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000884559	15	43552428	15	43260230	884559	873551		NC_000015.10:43260229:G:C
NM_201631.4(TGM5):c.1239G>A (p.Glu413=)	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000884498	15	43531121	15	43238923	884498	873542		NC_000015.10:43238922:C:T
NM_201631.4(TGM5):c.1552A>G (p.Asn518Asp)	TGM5	N436D, N518D	Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000884497	15	43527829	15	43235631	884497	873541		NC_000015.10:43235630:T:C
NM_201631.4(TGM5):c.125C>A (p.Thr42Asn)	TGM5	T42N	Peeling skin syndrome 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000778097	15	43552663	15	43260465	778097	703218	rs148913728	NC_000015.10:43260464:G:T
NM_201631.4(TGM5):c.10+11C>T	TGM5		Peeling skin syndrome 2|not provided	Benign(Last reviewed: May 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000316066	15	43559027	15	43266829	316066	338977	rs113296343	NC_000015.10:43266828:G:A
NM_201631.4(TGM5):c.11-11C>A	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000316065	15	43552788	15	43260590	316065	340571	rs200870480	NC_000015.10:43260589:G:T
NM_201631.4(TGM5):c.44C>G (p.Ser15Cys)	TGM5	S15C	Peeling skin syndrome 2|not provided	Benign(Last reviewed: May 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000316064	15	43552744	15	43260546	316064	338975	rs61744878	NC_000015.10:43260545:G:C
NM_201631.4(TGM5):c.167A>T (p.Asn56Ile)	TGM5	N56I	Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000316063	15	43552621	15	43260423	316063	332007	rs757831590	NC_000015.10:43260422:T:A
NM_201631.4(TGM5):c.282C>G (p.Thr94=)	TGM5		not provided|Peeling skin syndrome 2	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000316062	15	43552404	15	43260206	316062	340569	rs144607106	NC_000015.10:43260205:G:C
NM_201631.4(TGM5):c.654C>T (p.Pro218=)	TGM5		Peeling skin syndrome 2|not provided	Benign(Last reviewed: May 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000316061	15	43545734	15	43253536	316061	340567	rs77256087	NC_000015.10:43253535:G:A
NM_201631.4(TGM5):c.660C>T (p.Tyr220=)	TGM5		Peeling skin syndrome 2|not provided	Benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000316060	15	43545728	15	43253530	316060	332002	rs555001	NC_000015.10:43253529:G:A
NM_201631.4(TGM5):c.723C>G (p.Asn241Lys)	TGM5	N241K, N159K	Peeling skin syndrome 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000316059	15	43545096	15	43252898	316059	340565	rs35578968	NC_000015.10:43252897:G:C
NM_201631.4(TGM5):c.768G>A (p.Thr256=)	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000316057	15	43545051	15	43252853	316057	340563	rs200482481	NC_000015.10:43252852:C:T
NM_201631.4(TGM5):c.821G>A (p.Arg274His)	TGM5	R274H, R192H	Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000316056	15	43544998	15	43252800	316056	322560	rs116616135	NC_000015.10:43252799:C:T
NM_201631.4(TGM5):c.863-9T>C	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000316055	15	43533197	15	43240999	316055	331996	rs770164232	NC_000015.10:43240998:A:G
NM_201631.4(TGM5):c.897C>G (p.Ile299Met)	TGM5	I299M, I217M	Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000316054	15	43533154	15	43240956	316054	338969	rs886051172	NC_000015.10:43240955:G:C
NM_201631.4(TGM5):c.918C>T (p.His306=)	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000316053	15	43533133	15	43240935	316053	322556	rs886051171	NC_000015.10:43240934:G:A
NM_201631.4(TGM5):c.960C>T (p.Asn320=)	TGM5		not provided|Peeling skin syndrome 2	Benign(Last reviewed: May 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000316052	15	43533091	15	43240893	316052	340562	rs34222269	NC_000015.10:43240892:G:A
NM_201631.4(TGM5):c.989A>T (p.Lys330Met)	TGM5	K330M, K248M	Peeling skin syndrome 2|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000316051	15	43533062	15	43240864	316051	338967	rs201805126	NC_000015.10:43240863:T:A
NM_201631.4(TGM5):c.1055C>G (p.Ala352Gly)	TGM5	A352G, A270G	Peeling skin syndrome 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000316050	15	43531411	15	43239213	316050	322554	rs28756768	NC_000015.10:43239212:G:C
NM_201631.4(TGM5):c.1104C>T (p.Asn368=)	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000316049	15	43531362	15	43239164	316049	340559	rs150457385	NC_000015.10:43239163:G:A
NM_201631.4(TGM5):c.1106-7C>T	TGM5		Peeling skin syndrome 2|not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000316048	15	43531261	15	43239063	316048	340558	rs113249183	NC_000015.10:43239062:G:A
NM_201631.4(TGM5):c.1209C>T (p.Cys403=)	TGM5		Peeling skin syndrome 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000316047	15	43531151	15	43238953	316047	322553	rs375801160	NC_000015.10:43238952:G:A
NM_201631.4(TGM5):c.1252C>A (p.Gln418Lys)	TGM5	Q418K, Q336K	Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000316046	15	43531108	15	43238910	316046	322550	rs144961145	NC_000015.10:43238909:G:T
NM_201631.4(TGM5):c.1309C>T (p.Arg437Trp)	TGM5	R437W, R355W	Peeling skin syndrome 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000316045	15	43531051	15	43238853	316045	338960	rs375323388	NC_000015.10:43238852:G:A
NM_201631.4(TGM5):c.1471C>T (p.Pro491Ser)	TGM5	P491S, P409S	Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000316044	15	43527910	15	43235712	316044	338953	rs552005220	NC_000015.10:43235711:G:A
NM_201631.4(TGM5):c.1498C>T (p.Arg500Ter)	TGM5	R500*, R418*	Peeling skin syndrome 2	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000316043	15	43527883	15	43235685	316043	331982	rs144532387	NC_000015.10:43235684:G:A
NM_201631.4(TGM5):c.1510G>A (p.Val504Met)	TGM5	V504M, V422M	not provided|Peeling skin syndrome 2	Benign(Last reviewed: May 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000316042	15	43527871	15	43235673	316042	338952	rs7171797	NC_000015.10:43235672:C:T
NM_201631.4(TGM5):c.1562A>G (p.Gln521Arg)	TGM5	Q521R, Q439R	Peeling skin syndrome 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000316041	15	43527819	15	43235621	316041	331976	rs35985214	NC_000015.10:43235620:T:C
NM_201631.4(TGM5):c.1689G>A (p.Ala563=)	TGM5		Peeling skin syndrome 2|not provided	Uncertain significance(Last reviewed: Sep 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000316040	15	43527692	15	43235494	316040	340557	rs141734428	NC_000015.10:43235493:C:T
NM_201631.4(TGM5):c.1773C>T (p.Asp591=)	TGM5		not provided|Peeling skin syndrome 2	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000316039	15	43527069	15	43234871	316039	331975	rs142648722	NC_000015.10:43234870:G:A
NM_201631.4(TGM5):c.1820A>C (p.Glu607Ala)	TGM5	E607A, E525A	Peeling skin syndrome 2	Likely benign(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000316038	15	43527022	15	43234824	316038	331968	rs80192997	NC_000015.10:43234823:T:G
NM_201631.4(TGM5):c.1822A>G (p.Lys608Glu)	TGM5	K608E, K526E	Peeling skin syndrome 2	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000316037	15	43527020	15	43234822	316037	338950	rs76456763	NC_000015.10:43234821:T:C
NM_201631.4(TGM5):c.*56T>C	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000316036	15	43525333	15	43233135	316036	338948	rs533062951	NC_000015.10:43233134:A:G
NM_201631.4(TGM5):c.*252C>T	TGM5		Peeling skin syndrome 2	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000316035	15	43525137	15	43232939	316035	331966	rs7176183	NC_000015.10:43232938:G:A
NM_201631.4(TGM5):c.*430C>T	TGM5		Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000316034	15	43524959	15	43232761	316034	331962	rs577285021	NC_000015.10:43232760:G:A
NM_201631.4(TGM5):c.122T>C (p.Leu41Pro)	TGM5	L41P	not provided|Peeling skin syndrome 2	Uncertain significance(Last reviewed: Jun 18, 2020)	criteria provided, single submitter	VCV000157569	15	43552666	15	43260468	157569	167431	rs143601447	NC_000015.10:43260467:A:G
NM_201631.4(TGM5):c.763T>C (p.Trp255Arg)	TGM5	W255R, W173R	Peeling skin syndrome 2	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000157568	15	43545056	15	43252858	157568	167430	rs115677373	NC_000015.10:43252857:A:G
NM_201631.4(TGM5):c.1335G>C (p.Lys445Asn)	TGM5	K445N, K363N	not provided|Peeling skin syndrome 2	Conflicting interpretations of pathogenicity(Last reviewed: Mar 4, 2020)	criteria provided, conflicting interpretations	VCV000157567	15	43531025	15	43238827	157567	167429	rs606231276	NC_000015.10:43238826:C:G
NM_201631.4(TGM5):c.326C>T (p.Thr109Met)	TGM5	T109M	Peeling skin syndrome 2|not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000137639	15	43552360	15	43260162	137639	141342	rs113463533	NC_000015.10:43260161:G:A
NM_201631.4(TGM5):c.314G>A (p.Cys105Tyr)	TGM5	C105Y	Peeling skin syndrome 2|not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000137638	15	43552372	15	43260174	137638	141341	rs116753155	NC_000015.10:43260173:C:T
NM_201631.4(TGM5):c.337G>T (p.Gly113Cys)	TGM5	G113C	not provided|Inborn genetic diseases|Peeling skin syndrome 2	Pathogenic(Last reviewed: Mar 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006039	15	43552349	15	43260151	6039	21078	rs112292549	NC_000015.10:43260150:C:A
